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The Hmong, a minority Asian subgroup, have one of the highest rates of infectious 
hepatitis in the United States.  In 2014, the United States Preventive Services Task Force 
(USPSTF) expanded hepatitis B recommendations to include individuals born in hepatitis high 
prevalent regions and American born individuals not vaccinated as infants whose parents were 
born in very high prevalent regions. These regions include the Southeast Asian countries, areas 
where the Hmong people emigrated from.  
The project purpose was to increase hepatitis A (HAV), hepatitis B (HBV), and hepatitis 
C (HCV) risk assessments in adult patients, using the USPSTF’s 2014 HBV and 2013 HCV 
recommendations and the Centers for Disease Control and Prevention’s (CDC’s) HAV and HBV 
immunization recommendations.  The project used evidence-based interventions and the 
Diffusion of Innovation and Culture Care Theories.  Measures used in evaluating the intervention 
included provider and staff pre-test post-test surveys, a modified hepatitis risk assessment tool 
(HRAT), and qualitative feedback from clinic staff and community members.  The HRAT 
utilization was implemented among the patients of one provider.  Results were analyzed using 
frequencies, descriptive statistics, and paired t-tests to determine if perspectives on hepatitis risk 
screening changed from pre- to post- survey.   
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Attitudes and skills of staff and providers did not improve in six out of eight survey 
questions; however, the majority of the respondents reported positive views in risk screening in 
both the pre- and post-intervention surveys.  Knowledge scores improved 26.37 percentage 
points, with staff having the most improvement (+38.29%).  The provider screened 196 patients, 
with a 43% HRAT utilization rate.  This study found that 95.2% Hmong (n = 20 of 21) and 
92.3% Asian (n = 12 of 13) patients had the highest risk for HBV, with the 95.2% Hmong (n = 
20 of 21) and 100% Asian (n = 13) patients meeting the USPSTF’s recommendations.  
This project piloted interventions to increase hepatitis risk screening, increase patient 
hepatitis education, and improve provider recommendations to further improve patient outcomes 
for those who have viral hepatitis risks.  Further work is needed to identify ways to create a 
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CHAPTER 1: INTRODUCTION 
The viral communicable diseases, hepatitis A, hepatitis B, and hepatitis C, remain a 
global health threat despite the medical advancements over the past decades (Centers for Disease 
Control and Prevention [CDC], 2015).  The most common types in the United States are hepatitis 
B (HBV) and hepatitis C (HCV), and in rare cases hepatitis A (HAV) (CDC, 2016a).  Hepatitis 
A begins as an acute infection that can lead to debilitating symptoms, such as fever, vomiting, 
and diarrhea, with the potential to cause acute liver failure (CDC, 2015).  New or acute cases of 
HBV and HCV can also present with the same symptoms as HAV and develop into chronic 
infections, which can potentially lead to health problems, such as liver failure and liver cancer 
(CDC, 2019a).  
Understanding how hepatitis A, B, and C are transmitted is important to control and 
contain viral hepatitis infection.  Hepatitis A is associated with fecal to oral transmission from 
the feces of an infected person (CDC, 2019).  Hepatitis B risk is associated with contact to 
infectious blood, semen, and/or other body fluids through sexual contact, sharing of 
contaminated needles, or mother-to-infant transmission (CDC, 2019a).  Nearly 90 percent of 
infants with HBV infection later develop chronic HBV (CDC, 2019b).  Hepatitis C infection 
transmission is associated with exposure to infectious blood, and has been found to occur more 
commonly among adults born between 1945 and 1965, individuals who acquire tattoos in 
unregulated settings, past or current injection drug users, individuals with positive human 
immunodeficiency virus (HIV), or persons who have sexual contact with an HCV-infected 
partner (CDC, 2018a).  Additionally, many individuals with undiagnosed hepatitis are often 
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young, asymptomatic, and healthy, and as a result, the risk for transmission is high (Vijayan, 
2015).  
Trends of Outbreaks 
On a global scale, hepatitis A, B, and C occur in nearly every part of the world (World 
Health Organization [WHO], 2013).  However, the Asian, African, and South American 
continents have the largest share due to the low sanitary and hygienic conditions (McGlynn, 
Petrick, & London, 2015; WHO, 2017b).  In 2015, the WHO estimated that HAV accounted for 
0.9 percent of the world’s mortality from viral hepatitis, while 3.5 percent of the world’s 
population was living with chronic HBV and one percent with HCV (WHO, 2017a).  
Furthermore, more than 75 percent of the world’s deaths from viral hepatitis have 
occurred in Asia (McGlynn, Petrick, & London, 2015).  In Southeast Asia alone, the WHO 
estimates that there are 400 thousand HAV incident cases annually as of 2013, compared to 6700 
reported incident cases in the United States in 2017 (CDC, 2019; WHO, 2013).  In 2013, over 
100 million people were estimated to be living with hepatitis B, and 30 million people with 
hepatitis C in Southeast Asia, as compared to the United States with 3.5 million people with 
HBV in 2016 and 2.4 million with HCV in 2018 (CDC, 2018d; WHO, 2013; United States 
Department of Health & Human Services [USDHHS], 2016). 
In the United States, there were outbreaks of HAV between 2012 and 2016, which were 
linked to consumption of imported contaminated foods (CDC, 2018a).  The CDC received 
approximately 15,000 reports of individuals with hepatitis A infection from 2016 to 2018 alone 
(Walker, 2019).  The cumulative incidence of HBV increased 18.3 percent between 2011 and 
2015, while HCV amplified more than a 3.5-fold from 2010 to 2016 (CDC, 2015).  Despite 
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medical advancements and public health efforts, the hepatitis infection rates continue to rise in 
the United States.  
Viral Hepatitis Among the Asian Population   
There are 18.2 million Asian Americans living in the United States (U.S.) as of 2017 
(USDHHS Office of Minority Health, 2019).  Although this number only represents five percent 
of the U.S. population, more than one half of chronic HBV infections are Asian (CDC, 2016b).  
One out of every 12 Asian American have chronic HBV, as compared to one in 1000 non-
Hispanic whites in 2018 (FDA, 2018; Stanford Medicine Asian Liver Center, 2019).  
Approximately two-thirds of Asian individuals living in the United States who have HBV 
are unaware of their infection (Food and Drug Administration [FDA], 2018).  Correspondingly, 
the Asian population is at least eight times more likely to develop liver cancer from chronic 
hepatitis (CDC, 2016b).  Additionally, more than three quarters of individuals with chronic HBV 
infection are born outside the United States (CDC, 2018a; CDC, 2016b).  
Viral Hepatitis Among the Hmong Population  
The Hmong people, a minority subgroup within the Asian population, are originally from 
Southeast Asia.  As of 2015, the Hmong population in the United States is estimated to be nearly 
300 thousand (Pew Research Center, 2017).  They have the highest prevalence of infectious 
hepatitis compared to other Asian American groups and one of the highest rates in the United 
States overall (Dang & Chen, 2016; Gjerdingen & Lor, 1997; Mixson-Hayden et al., 2014; 
Sheikh, Atla, Ameer, Sadiq, & Sadler, 2012).  Hmong refugees have the highest rates of HBV 
and HCV infection compared to other refugee groups residing in the United States (Gjerdingen 
& Lor, 1997; Mixson-Hayden et al., 2014).  
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Hmong individuals, who are positive for hepatitis, are often diagnosed at a younger age 
(Sheikh et al., 2011; Nguyen et al., 2007).  The peak prevalence of HBV among Hmong persons 
was within the ages of 16 to 35 years old at the time of hepatitis diagnoses (Sheikh et al., 2011; 
Nguyen et al., 2007).  The literature consistently highlights hepatitis as an alarming issue in this 
group of people and especially among the younger Hmong adults (Dang & Chen, 2016; 
Gjerdingen & Lor, 1997; Sheikh et al., 2012). 
North Carolina Viral Hepatitis Statistics 
Hepatitis A, hepatitis B, and hepatitis C are reportable diseases in the state of North 
Carolina (North Carolina Department of Health and Human Services [NCDHHS], 2017b).  
Between 2018 and 2019, North Carolina experienced a hepatitis A outbreak, reporting 76 cases, 
including one death (NCDHHS, 2019b).  This state observed a rise of viral hepatitis over the past 
decade as new cases of HBV and HCV increased by 56 percent and 69 percent respectively from 
2014 and 2016 (NCDHHS, 2017a).  Between 2012 to 2016, North Carolina had a cumulative 
incidence increase of 0.91 per 100,000 population in acute HBV infections and 1.28 per 100,000 
of acute HCV infections (North Carolina Disease Data Dashboard [NCD3], 2019a).   
 Particularly, 81.9 per 100,000 hepatitis B cases were reported Asian and/or Pacific 
Islanders within the state of North Carolina in 2017 (NCDHHS, 2017b).  It is pertinent to note 
that published North Carolina demographic data, with regard to other ethnicities and viral 
hepatitis, have not been identified. 
Catawba County Viral Hepatitis Statistics 
From 2012 to 2016, Catawba County reported a cumulative incidence increase of 2.6 per 
100,000 population in HBV infections and 5.1 per 100,000 of HCV infections (NCDHHS, 
2017b).  The Public Health Department of Catawba County began routine screening for hepatitis 
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C in 2016 in response to the rising number of hepatitis reports between 2010 and 2014 after the 
United States Preventive Services Task Force (USPSTF) recommended screening in 2013 
(Catawba County Government, 2018b).  
Hmong Population in Catawba County, North Carolina 
In the United States, the fourth largest Hmong population resides in North Carolina 
(Hmong National Development, 2013; Catawba County Government, 2018a).  Approximately 
0.11 percent of North Carolina’s population or 10,864 residents reported being Hmong in the 
2010 United States Census (Hmong National Development, 2013).  There are 2,865 native 
Hmong speakers of the 155,460 people residing in Catawba County as of 2015 (Data USA, 
2015).  When compared to other parts of the country, this population percentage of Hmong 
residents is significantly high (Data USA, 2015).   
Although there are reported rates of the occurrence of hepatitis infections, published 
demographic data that identify the Hmong population have not been identified.  However, a 
physician assistant (PA) practicing in this region has taken note of the high prevalence of 
hepatitis infection among her Hmong patients.  At the PA’s primary care practice, she reports 
that about 15 to 20 percent of the patients identify as Hmong; and over the course of her 10 years 
of practice, she estimates that approximately five to 10 percent of those Hmong patients were 
diagnosed with HBV or HCV. 
Viral Hepatitis Immunization Guidelines 
Primary prevention.  The Advisory Committee on Immunization Practices (ACIP) and 
the CDC have specific recommendations for hepatitis A and hepatitis B immunizations 
(Appendices E and F).  The ACIP recommends the hepatitis A vaccination series for all patients 
who are older than 12 months old or refugee children ages 12 to 23 months old (CDC, 2014).  
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The hepatitis A vaccination is also recommended for individuals traveling to countries where 
hepatitis A is common and for men who have sex with other men (CDC, 2016c).  Hepatitis B 
vaccination is recommended for infants within 24 hours of birth, followed by the hepatitis B 
vaccination series (CDC, 2018d).  For adults who have never been vaccinated before, the 
hepatitis B vaccination is suggested for all adults who are at risk for HBV infection or for anyone 
requesting HBV protection (CDC, 2018c).  
Viral Hepatitis Screening Guidelines 
For the purpose of this Doctorate of Nursing Practice (DNP) project, the USPSTF 
guidelines were utilized for screening patients for hepatitis B and C virus infection in the primary 
care clinic located in Catawba County (Table 1). 
Secondary prevention.  The USPSTF guidelines assign a grade of "B" recommendation 
for screening high-risk individuals for HBV and HCV infection, meaning primary care providers 
should offer or provide this service (USPSTF, 2014; USPSTF, 2013).  The HBV guidelines were 
revised in 2014 (USPSTF, 2014).  The USPSTF expanded the definition of HBV “high-risk 
individuals” to include individuals who were born in regions with a high prevalence of hepatitis 
and American-born individuals not vaccinated as infants whose parents were born in very high 
prevalence regions (USPSTF, 2014; CDC, 2016a; Sarin et al., 2016; Nguyen & Lin, 2015).  
These regions include the Southeast Asian countries where viral hepatitis is endemic, regions 
where the Hmong people primarily originated and emigrated from (USPSTF, 2014; Kue & 
Thorburn, 2013).  Additionally, the USPSTSF recommends screening for HCV because there is 
treatment available for HCV.  
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Table 1. The United States Preventive Services Task Force 2013 & 2014 Recommendations for 
Hepatitis B and C Screening. 
Population Recommendation Grade Year  
Persons at High 
Risk for 
Infection 
The USPSTF recommends screening for 
hepatitis B virus infection in persons at high 
risk for infection. 
B 2014 
Adults at High 
Risk 
The USPSTF recommends screening for 
hepatitis C virus infection in persons at high 
risk for infection. The USPSTF also 
recommends offering 1-time screening for 




Tertiary prevention.  Currently, the USPSTF does not have guidelines for HAV 
screening.  However, for tertiary prevention measures, the CDC recommends diagnostic blood 
test screening for HAV only if patients are symptomatic (CDC, 2014).  
Effects of Provider Knowledge on Viral Hepatitis Screening 
Primary care providers are accountable for managing the overall care of patients, such as 
keeping patients up-to-date with immunizations and health maintenance as recommended by 
professional organizations and nationally recognized guidelines (CDC, 2016a).  However, 
primary care provider screening recommendation rates for hepatitis are low among Asian 
populations (Khalili et al., 2011; Kue & Thorburn, 2013).  Furthermore, in a cross-sectional 
study of 109 provider participants, only 75 percent of the participants screened over 50 percent 
of their Asian patients (Khalili et al., 2011).  In a narrative review study evaluating the barriers of 
HBV care in Asian and/or Pacific Islander Americans, the authors found that providers who have 
more hepatitis knowledge are more likely to screen patients (Hu, 2008).  In contrast, providers 
with less knowledge of hepatitis are less likely to screen their patients (Hu, 2008; Khalili et al., 
2011; Kue & Thorburn, 2013).  Correspondingly, two-thirds of 83 Hmong participants in a 
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qualitative study reported that their providers never recommended a screening for hepatitis (Kue 
& Thorburn, 2013).   
Problem Statement 
The result of these aforementioned factors is that some providers fail to adhere to the 
updated guidelines in screening high-risk populations, including the Hmong people (Kue & 
Thorburn, 2013; Nguyen, et al., 2007; Nguyen & Lin, 2015; Hu, 2008).  Therefore, Hmong 
patients who have undetected hepatitis A, B, and C are more likely to live with it, less likely to 
receive treatment, and at risk for unknowingly infecting others.  These consequences result from 
providers who are less aware of the high prevalence of viral hepatitis A, B, and C among the 





CHAPTER 2: PURPOSE STATEMENT 
The purpose of this DNP performance improvement project was to increase hepatitis A, 
hepatitis B, and hepatitis C risk assessments in asymptomatic Hmong adult patients.  Following 
the USPSTF recommendations for Hepatitis B and C screening and the CDC’s recommendation 
for Hepatitis A and B immunizations, the goals of the DNP project were to: 
1. a)  Implement evidence-based behavior change interventions to improve provider and 
clinician behaviors in conducting routine hepatitis risk assessments by providing information 
sessions on:   
i. Hepatitis A, B, and C transmission and risk factors 
ii. Vaccination guidelines 
iii. Routine hepatitis risk assessment screenings 
iv. Prevalence and incidence of hepatitis among the Hmong population in Catawba 
County, North Carolina 
 b)  Evaluate whether improvements were achieved for the following outcomes among 
providers and staff using a pre- and post- intervention survey (Appendices B and C):  
i. Attitudes of the critical need to screen patients for hepatitis A, B, and C 
ii. Confidence level in screening for hepatitis A, B, and C risk assessment (Skills) 
iii. Knowledge of hepatitis A, B, and C  
2. Implement an assessment process using the Hepatitis Risk Assessment Tool (HRAT) 
(Appendix A) adopted from the CDC.  It is recommended that patients who have a positive 
hepatitis risk screen not only receive education but are also referred for follow up or diagnostic 
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testing, and those in need of vaccinations for hepatitis A and B are encouraged to receive them 
(CDC, 2018d; CDC, 2014; USPSTF, 2014; USPSTF, 2013).  This tool was offered to adult 
patients ages 18 years and older seen by the PA at a primary care setting in Catawba County 
from September 5 to November 26, 2019 to:  
a) Identify at-risk patients for hepatitis A, B, and C 
b) Assess provider recommendations, including referrals, diagnostic tests, vaccinations, 
and/or follow up plans for patients with positive hepatitis risk assessment screens  
c) Raise awareness and offer educational pamphlets from the CDC on hepatitis A, B, 
and C to patients 
3. Offer an informal community education outreach by organizing an informational booth to 




CHAPTER 3: REVIEW OF LITERATURE 
A literature review was conducted in November 2018 to inform this project and place it 
within the greater context of risk screening for hepatitis in asymptomatic Hmong adults. 
Search Strategy 
 I used the computer databases, PubMed Central and Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), to identify research articles related to the Hmong people and 
hepatitis risk screening in primary care.  Keywords that were used and merged for this topic 
included: Hmong, Asians, Asian Americans, hepatitis, screening, risk screening, detection, mass 
screening, health screening, risks, and health status indicators.  I did not set limitations on this 
comprehensive detailed search to locate more information, recommendations, and strategies 
specific for the project.  The searches varied by using medical headings and keywords in addition 
to combining Medical Subject Headings (MeSH) terms and All Fields index for each keyword.  
 Two hundred ninety records were obtained during the initial search of the two databases.  
After removing duplicate articles, 218 publications remained.  Subsequently, 178 articles were 
excluded based on the following criteria: (a) irrelevance to hepatitis screening, (b) focus on 
ethnic groups other than Asian, and (c) studies on Asian people living outside of the United 
States.  After screening for potential article eligibility, 31 additional articles were excluded 
because of a focus on: (e) prevention, treatment, or management of hepatitis exposure, (f) 
hepatocellular carcinoma or other cancers, (g) screenings in dental practice, (h) screenings at 
onset of chemotherapy, (i) prevalence of other viruses, and (j) other medical health screenings.   
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One additional article was added because it studied the use of a hepatitis C screening tool 
(Nguyen, Herrine, Laine, Ruth, & Weinberg, 2005).  This article was found in a separate search 
in PubMed. Although this article included other study characteristics that were not relevant to the 
Hmong or Asian population, the article was necessary to explore the appraisal of evidence for the 
purpose of this project.   
Ultimately, nine articles are included in the literature summary to guide the planning and 
implementation of an intervention involving the use of a HRAT for Hmong adults in primary 
care settings.  The study data from the articles were extracted and organized into a matrix of 
evidence table (Appendix D).  
Study Characteristics 
 The nine studies identified were published between 2005 and 2017.  Six of the studies 
took place in the state of California (Hu, 2008; Khalili et al., 2011; Lin, Chang, & So, 2007; 
Nguyen & Lin, 2015; Nguyen, Taylor, Chen, Bastani, Maxwell, & McPhee, 2007; Sheikh, 
Mouanoutoua, Walvick, Singh, Stoltz, & Mills, 2011), one in the Baltimore-Washington region 
(Juon, Rimal, Klassen, & Lee, 2017), one in Oregon (Kue & Thorburn, 2013), and one in 
Pennsylvania (Nguyen et al., 2005).   
Study designs of the articles used in the literature review included one randomized 
controlled study (Juon et al., 2017), four cross sectional studies (Khalili et al., 2011; Lin et al., 
2007; Nguyen et al., 2005; Sheikh et al., 2011), one literature review (Nguyen et al., 2007), one 
qualitative study (Kue & Thorburn, 2013), one narrative review (Hu, 2008), and one expert 
opinion publication (Nguyen & Lin, 2015). 
 The study samples ranged from 83 to 3163 participants.  Most of the studies included 
limited statistical data.  Additionally, the risk of bias, in terms of funding, is categorized as 
 
13 
moderate because of grants from associated organizations.  Publications by Nguyen et al. (2005) 
and Nguyen et al. (2007) were funded by the Schering-Plough Corporation and the Liver Cancer 
Control Interventions for Asian Americans, respectively, while three studies did not specify their 
source of funding (Hu, 2008; Nguyen & Lin, 2015; Sheikh et al., 2011).  
 Convenience and purposive sampling were heavily utilized in six of the studies to recruit 
participants (Khalili et al., 2011; Lin et al., 2007; Nguyen et al., 2005; Sheikh et al., 2011; Kue & 
Thorburn, 2013; Juon et al., 2017).  In particular, one study informed people of a monetary 
stipend for participating and also provided compensation for transportation and childcare (Kue & 
Thorburn, 2013).  Purposive and intentional sampling were advantageous for these studies to 
target participants meeting the requirements for the studies. 
 Furthermore, another potential bias concern is the possibility that participants responded 
in ways they believed researchers would prefer (Kue & Thorburn, 2013; Sheikh et al., 2011).  
Additional limitations were participation reluctance, population generalizability, and/or 
participants not completing all answers because of privacy concerns or close personnel 
safeguarding (Kue & Thorburn, 2013; Juon et al., 2017; Khalili et al., 2011; Lin et al., 2007; 
Nguyen et al., 2005; Sheikh et al., 2011).  Overall, because of the limitations of the studies, 
which includes the use of the observational study designs, narrative review, and expert opinion 
article, the risk of bias is ranked moderately high for this review of literature. 
Sample Characteristics in Literature Review 
 A total of 4973 participants were included in six of the articles (Juon et al., 2017; Khalili 
et al., 2011; Kue & Thorburn, 2013; Lin et al., 2007; Nguyen et al., 2005; Sheikh et al., 2011). 
Approximately 55 percent of the participants were women, and 37 percent were men.  Nguyen 
and colleagues (2007) did not specify the number of articles or characteristics of participants in 
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their literature review.  The narrative review by Hu (2008) included Asian and Pacific Islander 
Americans, but did not indicate the number of subjects or study characteristics.  Additionally, the 
qualitative review (Kue & Thorburn, 2013) and one cross sectional study (Nguyen et al., 2005) 
did not specify further study characteristics in their articles with respect to females versus males.  
All participants met the inclusion criteria specified for this literature review.  
Results of Literature Review Comparison 
 After conducting a thorough literature appraisal, three common patterns were identified 
that support the problem of hepatitis among the Hmong people: 1) high prevalence of hepatitis B 
in the Hmong population, 2) hepatitis B prevalence in younger Hmong individuals, and 3) the 
association between primary care provider knowledge and hepatitis screening practices (Nguyen 
et al., 2007; Nguyen & Lin, 2015; Hu, 2008, Khalili et al., 2011, Kue & Thorburn, 2013; Sheikh 
et al., 2011).  These themes are consistent with literature described in chapter one. 
 Hepatitis prevalence among Hmong Americans.  The high prevalence of hepatitis 
specific to Hmong Americans was reported in two cross sectional studies (Kue & Thorburn, 
2012; Sheikh et al., 2011).  In one study, one out of every six Hmong immigrants who were 
screened for HBV screened positive (Sheikh et al., 2011).  Results of the two articles, in addition 
to another cross sectional study analyzing Asian populations, were harmonious in revealing that 
at least 65 percent of Asian or Hmong adults in these studies had a positive HBV screen and 
were unaware of their liver infection (Kue & Thorburn, 2013; Lin et al., 2007; Sheikh et al., 
2011).  Additional evidence identified that many Hmong individuals lack knowledge of the 
disease and prevention measures; and consequently, over 50 percent of Hmong individuals are 
not vaccinated for HBV (Sheikh et al., 2011).  
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 Hepatitis B among young Hmong adults.  In both the cross sectional study (Sheikh et 
al., 2011) and the literature review (Nguyen et al., 2007), it is evident that hepatitis B affected 
Hmong individuals younger in age.  Interestingly, these individuals had more hepatitis 
awareness, had a higher education level, were young at immigration, or had family members 
with chronic hepatitis (Nguyen, et al., 2007).  In contrast, in another study the average age of 
Hmong adults with hepatitis infection is approximately 40 years old, while the peak prevalence 
of HBV among Hmong persons was within the ages of 16 to 35 years old (Sheikh et al., 2011).  
Results from these articles further support the high prevalence of hepatitis B in early adult 
Hmong people, and that clinicians are not routinely conducting hepatitis screening among 
persons born outside the baby boomer age who are eligible for screening.  
 Provider knowledge of hepatitis screening.  Primary care providers (PCPs) are 
responsible for managing the overall care of patients, as recommended by professional 
organizations and guidelines (CDC, 2016).  Evidence shows that many Asian Americans rely on 
provider recommendations for primary and secondary preventive care (Kue & Thorburn, 2013; 
Nguyen, et al., 2007).  While PCPs often adhere to the hepatitis C screening guidelines for 
patients born between 1945 and 1965, the results of several studies have shown that PCPs 
frequently fail to screen other groups of high-risk people, as evidenced by a qualitative study (n= 
82) (Kue & Thorburn, 2013), a literature review (Nguyen, et al., 2007), an expert opinion article 
(Nguyen & Lin, 2015), and a narrative review (Hu, 2008).           
 Some providers are unaware that the 2014 USPSTF guidelines cover the Southeast Asian 
countries where the Hmong people originated from (CDC, 2016; Kue & Thorburn, 2013; 
Nguyen & Lin, 2015; Sarin et al., 2016;).  Consequently, the level of provider knowledge and 
expertise may be linked to hepatitis screening rates, as evidenced by one cross sectional study in 
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California (Khalili et al., 2011).  Providers with less knowledge of hepatitis have been shown to 
be less likely to screen their patients; and in contrast, those with more knowledge are more likely 
to screen, based on the results of one narrative review, cross sectional study, and one qualitative 
study (Hu, 2008, Khalili et al., 2011, Kue & Thorburn, 2013).  Two-thirds of Hmong participants 
(n=83) in one qualitative study reported never having received a recommendation by a provider 
to be screened for hepatitis (Kue & Thorburn, 2013).  Correspondingly, in a study examining 
provider hepatitis screening practices, only three-fourths of providers (n = 109) screened over 
half of their patients identified as Asian (Khalili et al., 2011).  Particularly, most providers in a 
qualitative study were less aware of the high prevalence of hepatitis among Hmong Americans 
(Kue & Thorburn, 2013).  The evidence discussed here suggests that a large gap exists between 
provider hepatitis screening initiatives that target the Hmong population.  
Evidence to Support Need to Increase Hepatitis Risk Screening 
 In conducting the literature search for this project, I did not identify published studies that 
specifically involved a secondary prevention approach in Hmong or Asian populations by 
implementing the CDC’s HRAT or any form of a hepatitis risk screening tool within primary 
care practices.  Rather, many of the identified studies analyzed hepatitis screenings through 
blood samples.  Qualitative studies that had similar screening approaches among different groups 
of people in other countries briefly discussed the idea of questioning patients prior to hepatitis 
blood screening, and this was speculated to be more cost effective (Harris, Ward, & Gore, 2016; 
Sweeney et al., 2016).  Only one identified cross sectional study implemented a 72-question 
survey to screen for HCV in patients (n=207) at a gastroenterology specialty clinic, and reported 
1.5 percent of participating patients were HCV positive (Nguyen et al., 2005).  These findings 
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are suggestive that this may be the first HRAT administered via questionnaire to be studied and 
implemented among high-risk Hmong population from a primary care standpoint. 
Assessment of the Evidence 
 Several identified and reviewed studies support the need to implement the use of a 
hepatitis risk assessment process with adult Hmong Americans in this quality improvement 
project.  The evidence included four published cross sectional studies, one literature review, one 
narrative review, one qualitative study, one randomized controlled study, and one expert opinion 
publication.  The randomized control study has the strongest evidence; however, the study was of 
minor relevance to this project topic, examining social norms and behavior in HBV positive 
Asian Americans rather than screening for hepatitis (Juon et al., 2017).  Despite the potential bias 
factors that weaken the evidence, as discussed previously, the four cross sectional studies are 
moderately strong and had relatively large sample sizes, ranging from 109 to 3,163 research 
participants.  Other strengths of this review of literature include a strong and broad 
representation of the Hmong or Asian population by age and sex within the studies.  
 When applying the nursing evidence hierarchy pyramid and Melnyk’s Level of Evidence 
model (Melnyk, 2011; Schmidt & Brown, 2015) to rate the quality of evidence, Juon et al. 
(2017) was rated as having the highest quality, Khalili et al. (2011), Lin et al. (2007), Nguyen et 
al. (2005), and Sheikh et al. (2011) were rated as moderate quality, while Nguyen et al. (2007), 
and Kue & Thorburn (2013) were rated as having low quality.  Finally, Hu (2008) and Nguyen & 
Lin (2015) were rated very low quality.  Overall, the quality of evidence addressing the purpose 
statement of this project is moderately low based on the hierarchy research pyramid and 
Melnyk’s model (Melnyk, 2011; Schmidt & Brown, 2015).  
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Application of the Review of Literature and Summary 
 The prevalence of hepatitis among Hmong Americans is not only a major concern when 
compared to other Asian communities, but they are recognized as the minority population with 
the highest rates of hepatitis (Dang & Chen, 2016; Gjerdingen & Lor, 1997; Mixson-Hayden et 
al., 2014; Sheikh et al., 2012).  The analysis from this review of literature established that 
Hmong individuals are part of the high-risk populations observed within the United States.  This 
literature review further identified that younger adult Hmong individuals have high rates of HBV 
and liver diseases when compared to the older adults; and provider barriers are associated to poor 
hepatitis screening rates (Hu, 2008, Khalili et al., 2011, Kue & Thorburn, 2013; Nguyen et al., 
2007; Sheikh et al., 2011). 
 As a result, this review of literature supports the purpose of this DNP project, to improve 
screening rates and subsequent identification of hepatitis in asymptomatic Hmong adults by 
implementing a HRAT in primary care settings.  Based on the evidence from this review, the 
screening tool is likely to be associated with initiating treatment earlier in the course of the 
disease to ultimately improve potential outcomes among Hmong individuals who are unaware of 
their liver disease.  
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CHAPTER 4: THEORETICAL FRAMEWORK 
The Diffusion of Innovations Theory 
The Diffusion of Innovations (DoI) Theory, developed by Everett Rogers, was used as 
the framework to guide the design and implementation of this DNP project (Rogers, 2003; 
Barrow & Toney-Butler, 2019).  The DoI Theory refers to the process that occurs as people 
adopt a new idea or practice in a clinical setting and the attributes of interventions that help to 
facilitate adoption of an innovation (Barrow & Toney-Butler, 2019).  This theory helped identify 
barriers to a practice change and also assisted with developing strategies for process 
improvement for the DNP project, using the five stages of adoption processes: knowledge, 
persuasion, decision, implementation, and confirmation (Table 2) (Rogers, 2003).  Greenhalgh 
and colleagues (2004) expanded the DoI Theory to encompass six key attributes that helped 
facilitate successful adoption of innovation (Table 3).   
Table 2. Five Components of the Diffusion of Innovation Theory and Definitions 
Knowledge Intended adopters are exposed to innovation but lack complete information 
Persuasion Intended adopters become interested in the new innovation and seeks 
additional information 
Decision Intended adopters mentally apply innovation to practice and anticipated 
future practice, and then decide whether or not to adopt it 
Implementation Intended adopters make full use of innovation 





Table 3. Diffusion of Innovation Theory’s Six Attributes and Definitions  
Relative 
Advantage 
Innovation has a clear, unambiguous advantage in either effectiveness or 
cost-effectiveness that is easily adopted  




Innovation is perceived as simple to understand and use by intended 
adopters 
Trialability Innovation offers ability for experimentation and use on trial basis 
Observability Benefits of the innovation are visible to intended adopters 
Reinvention Innovation allows intended adopters to adapt, refine, or modify the 
innovation to their own needs 
 
 
The Culture Care Theory 
 The Culture Care Theory (CCT), developed by Madeleine Leininger, is a secondary 
theory that served as a supportive foundation to DNP project implementation.  It is a framework 
to support the implementation of an evidence-based approach to deliver quality care that is 
culturally appropriate to the target population, the Hmong people (Fang & Stewart, 2018; 
Leininger, 1996; McFarland & Eipperle, 2008).  The CCT consists of interrelated ideas of 
cultural awareness in health care and sets principles of culture care into practice and research 
(Leininger, 1996).  There are multiple valuable concepts in Leininger’s Culture Care Theory, 
including cultural-congruent care, preservation, accommodation, re-patterning, and restructuring 
(Leininger, 1996).   
The most applicable concepts that are applied in this DNP project are culture care 
preservation and cultural care accommodation (Leininger, 1996).  Cultural care preservation or 
maintenance are the actions taken by the health care providers or staff to preserve or maintain a 
patient’s cultural views while providing care (Leininger, 1996).  Cultural care accommodation or 
negotiation occurs when actions are taken to accommodate a patient’s cultural beliefs into care 
provided or find negotiation to meet desired health outcome (Leininger, 1996).   
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Diffusion of Innovations Theory and Culture Care Theory in the DNP Project 
 This DNP project used the DoI framework to assist with practice change in increasing 
routine hepatitis risk assessments at the project setting.  Meanwhile, the two concepts from the 
CCT were used to guide providers and staff in providing culturally competent care to Hmong 
patients during health care delivery.  Both theories are aligned with the project purpose by 
supporting proactive efforts to enhance hepatitis risk screening, prevention, and management for 
improving health care to vulnerable and culturally diverse populations.  See Chapter 5 for 





CHAPTER 5: METHODOLOGY 
Purpose and Setting 
The purpose of this DNP performance improvement project was to increase hepatitis A, 
B, and C risk assessments in asymptomatic Hmong adult patients.  The setting for this DNP 
project was at a primary care clinic located in Catawba County, North Carolina that serves a 
large Hmong population.  The clinic reports that this practice sees approximately 100 patients 
daily.  On a yearly basis, about 50 percent of the patients are females and 50 percent are males, 
while less than one percent are transgender or other.  The majority of the patients served are 
between 30 to 60 years old.  The racial composition of the patient population is approximately 60 
percent White, 25 percent Black, and the remaining 15 percent are either Asian, Hispanic, or 
unknown.  
This office clinic accepts patients who have private insurance, Medicaid, Medicare, or are 
self-pay.  About 25 percent of the patients have private or commercial insurance, 25 percent have 
Medicare, 45 percent have Medicaid, and five percent are self-pay.  The clinic does not accept 
patients who are insured by Humana.  
 This site was selected for the project because it serves a large Hmong patient population, 
approximately 15 to 20 percent.  It is likely that Hmong patients are attracted to this practice 
because two staff, the physician assistant (PA) and licensed practical nurse (LPN), are Hmong 
and speak the language fluently.  Additionally, this location is easily accessible by motor 
vehicles or public transportation.  
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Project Design, Practice Improvement Description, Assessment, and Population Focus 
This DNP scholarly project was designed as a practice performance improvement 
initiative aimed to increase hepatitis A, B and C risk screening in a primary care setting during 
the intervention period from September 4, 2019 to December 13, 2019.  At the time of this study, 
there was no formal protocol or tool used for the hepatitis risk screening process that involved 
providers, staff, or patients.  One goal of this project was to implement an assessment process 
using the HRAT (Appendix A), adopted from the CDC, and follow up any positive screens with 
diagnostic lab tests and/or immunizations. 
There were three parts to this project to meet the DNP project goals.  These are 
categorized by target population and design and will be described in this section as parts 1, 2 and 
3: 1) a pretest-posttest educational intervention with providers and staff; 2) utilization of a 
HRAT; and 3) a community education outreach to the Hmong population.  
Part 1: A pretest-posttest educational intervention with providers and staff.  This 
practice performance improvement initiative involved the use of surveys (Appendices B and C) 
to evaluate providers’ and staff’s attitudes, skills, and knowledge on hepatitis risk screening and 
assessment at the beginning of the project and then again at the end of the project.  These 
assessments occurred after the DNP student had provided information sessions to them along 
with feedback.  Educational topics included hepatitis A, B, and C transmission and risk factors; 
vaccination guidelines; routine hepatitis risk assessment screenings and prevalence and incidence 
of hepatitis among the Hmong population in Catawba County, North Carolina.  The practice 
consists of four providers, including three physicians and one PA, and eight staff, including two 
certified medical assistants, one LPN, three front desk staff, one laboratory technologist, and one 
office manager (OM), that were eligible to participate in the surveys.  
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Part 2: Utilization of a hepatitis risk assessment tool.  A hepatitis risk assessment tool 
was used in this practice improvement project with the aim of increasing hepatitis risk screening 
in a primary care clinic in Catawba County, North Carolina.  The target population for Part 2 was 
adult patients ages 18 years and older who were seen by the PA during the 12-week intervention 
period from September 5, 2019 to November 26, 2019 for routine visits, annual physical 
examinations, or acute visits with a special focus on the results of patients that self-identified as 
Hmong. 
Part 3: A community education outreach to the Hmong population.  A community 
education outreach intervention was used to increase hepatitis A, B, and C awareness in the 
Hmong community.  Community members who attended the Hmong New Year Celebration in 
Catawba County on November 29, 2019 were the target population for Part 3 of this project.  
Data Collection and Screening Tools 
 Several data collection and screening tools were used in this project, including pre- and 
post- intervention surveys and a HRAT.  The purpose, source, and features of each are described 
below.  
Pre- and post- intervention surveys.  An 18-question survey was used to assess 
providers’ and staffs’ views on hepatitis risk screening.  The survey served as both the pre- and 
post- intervention surveys (Appendices B and C).  It was developed by the DNP student under 
the guidance of committee members. The questions were created and ranked according to the 
third level of Bloom’s taxonomy three learning domains: affective (attitude), psychomotor 
(skills), and cognitive (knowledge) (Adams, 2015).  Survey questions of each domain were 
developed from a literature review and based on input from experts in the field. 
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The attitudes and skills questions were modeled after the Perceived Health Competence 
Scale (PHCS) (Wallston, Osborn, Wagner, & Hilker, 2011) and the Perceived Medical Condition 
Self-Management Scale (PMCSMS) (Jacobson Vann et al., 2015).  The PHCS and PMCSMS are 
tools found to have validity in previous studies regarding HIV, diabetes, and kidney disease 
(Jacobson Vann et al., 2015; Wallston et al., 2011).  Questions from the PHCS and PMCSMS 
were tailored to meet the needs of this project purpose, to assess staff and providers’ attitudes 
and skills in hepatitis risk screening.  Additionally, knowledge questions were created based on 
content from the CDC that is available to the public (CDC, 2019). 
The attitudes and skills section consisted of four questions for each section.  The answer 
choices for the attitudes and skills sections were rated using the five-point Likert scale.  The 
choices were as follows: 1 = strongly disagree, 2= disagree, 3= neither agree or disagree, 4 = 
agree, 5 = strongly disagree.  Additional responses included “don’t know” and “not applicable 
(N/A).”  Participants were instructed to circle one answer in the attitudes and skills sections.  The 
knowledge section consisted of 10 questions and were in the form of select-all-that-apply.  The 
select-all-that-apply answer choices also included “Other,” “Don’t Know,” and “N/A.”  Each 
survey took approximately 10 minutes to complete.   
Hepatitis Risk Assessment Tool.  A hepatitis risk assessment tool was used to assist and 
guide providers in hepatitis risk screening.  Other purposes of the tool were to collect patient 
demographic data and evaluate provider education and recommendations.  Additionally, the tool 
was offered in the Hmong and English languages to overcome language barriers and health 
literacy for the target population of this project.  
The HRAT (Appendix A) was developed by the DNP student in collaboration with the 
PA and under the guidance of the committee members. This tool included 15 hepatitis A, B, and 
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C risk assessment questions adapted from the CDC’s hepatitis risk assessment tool (CDC, 
2018b) that is made available to the public.  These risk assessment questions were developed by 
the CDC based on known hepatitis A, B and C risk factors (CDC, 2018b).  Each positive risk 
factor is paired with recommendations from the CDC and reflected in the HRAT for provider use 
(CDC, 2018b).  Response options for each question are: “yes,” “no,” “don’t know,” or “not 
applicable.”  For the purposes of this DNP Project, this was the first time this modified HRAT 
was used; therefore, data on reliability or sensitivity of the tool are not available.  It was 
recommended by the CDC that any positive “yes” responses to risks identified by the CDC 
assessment questions be followed up with lab tests and/or vaccinations for Hepatitis A or B as 
recommended. 
This one-page tool consists of four sections: patient demographics, risk assessment 
questions, provider assessment, and provider recommendations.  The demographic section asks 
for patients’ age range, sex, ethnicity, and insurance type.  Patients were directed to select only 
one option in each part of the demographics section.  Age selection was presented in age ranges 
to avoid identification of patients retrospectively.  Patients who identify as Hmong and/or Asian 
could only choose one option; they were not encouraged to choose both.  Hmong patients were 
likely to choose the “Hmong” option.  The provider was given the option to select all that apply 
answer choices in the “Provider Use Only” and “Provider Recommendation” sections of the 
HRATs.  If patients declined hepatitis education and/or provider recommendations, the provider 




Part 1: staff and provider attitudes, skills, and knowledge. 
First information session for providers and staff. Two information sessions were 
delivered in the form of an in-service lunch and learn with the providers and staff at the project 
site.  The first session was held on September 4, 2019.  This session served three purposes: 1) to 
launch the DNP project, 2) to have staff and providers complete a pre-intervention survey 
(Appendix B), and 3) to educate staff and providers on viral hepatitis and screening guidelines.   
To obtain a baseline of the providers and staff’s attitudes, skills, and knowledge 
regarding hepatitis A, B and C, providers and staff were asked to complete the pre-intervention 
survey (Appendix B) at the start of the session prior to the hepatitis education presentation.  Prior 
to administering the pre-intervention survey (Appendix B), each staff member and provider was 
assigned a participant identification (PID) number.  The participant’s PID number was 
documented on his or her respective pre-tests and post-tests.  The list matching each participant’s 
name to his or her PID number was kept in a secure location separate from the data collected 
during this project to protect confidentiality of the data.   
Copies of the HRAT were given to everyone who attended the information session; they 
were informed that this tool was adapted from the CDC to conduct assessments for hepatitis A, 
B, and C.  Copies of PowerPoint presentation handouts, that included information to support the 
DNP project, were then given to the staff and providers (Appendix H).  The handout included 
information on viral hepatitis A, B, and C transmission and risk factors obtained from the CDC, 
screening and vaccination recommendations, hepatitis statistics among the Hmong population, 




Project team training on the Hepatitis Risk Assessment Tool.  The project team was 
identified at the first information session, which consisted of the PA, the LPN, and the office 
manager (OM).  They were introduced to and given an in-depth information session about the 
HRAT (Appendix A) and intervention process.  They were given a step-by-step risk screening 
process change guide that included staff responsibilities (Appendix I).  The DNP student also 
held a practice run-through with the project team using the HRAT during this training.  
Project team reminders and performance feedback. Throughout the intervention period, 
the DNP student made weekly contact with the project team’s PA and LPN via email or in-
person.  In-person site visits were scheduled every two to three weeks to support and encourage 
the project team members about the hepatitis risk screening process.  During each team member 
encounter, the Plan-Do-Study-Act (PDSA) approach was used to address barriers that arose 
pertaining to the HRAT utilization process.  The project team members were encouraged to 
report any concerns or barriers to the DNP student.  Performance feedback was delivered in both 
verbal and written form to project team.  The DNP student kept weekly field notes as a reminder 
to follow up on project activities (Appendix J). 
Final information session for providers and staff. After the 12-week interventional 
period, using the HRAT, the final information session was held on December 13, 2019 at the 
project site.  At this session, the DNP student reviewed the information and PowerPoint handout 
(Appendix H) that was provided at the first session with the staff and providers.  Preliminary 
HRAT results were also presented.   
Afterwards, providers and staff that took the pre-intervention survey were asked to 
complete the post-intervention survey (Appendix C).  They were also asked to give informal 
comments and feedback on the project.  The DNP student led group discussions for shared 
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learning and communicated with the stakeholders, specifically the staff and providers, about the 
project.  The DNP student also led discussions that focused on the sustainability of the 
intervention and ways that the risk screening process can be improved to fit the needs to the 
practice.   
Management and analysis of survey data. Responses for the two surveys were entered 
into an Excel sheet for each participant and each question.  These data were then transferred to 
the Statistical Package for the Social Sciences (SPSS) Data Analysis Software program.  
Completed pre- and post-intervention surveys were matched using PID numbers and analyzed 
using frequencies and dependent t-tests to look for changes in attitudes, skills, and knowledge 
pertaining to hepatitis risk screening, for each question.   
Analysis of attitudes and skills of staff and provider survey responses. Staff and 
providers’ attitudes and skills survey responses were analyzed using frequencies and categorized 
into positive and negative responses.  The frequency of the pre- and post- intervention survey 
attitudes and skills responses were manually computed as counts and percentages for each 
question.  A participant response of “strongly agree” or “agree” are considered positive answers, 
“strongly disagree” and “disagree” are negative answers, and “Neither Agree or Disagree,” 
“Don’t Know,” and “Not Applicable (N/A)” are considered neither.  If a participant did not 
answer the question with a response of “strongly disagree,” “disagree,” “agree,” or “strongly 
agree” their answer was not included in the overall analysis of that question.  Therefore, the 
number of participants may vary with each topic. 
Analysis of knowledge of staff and provider survey responses. The staff and providers’ 
knowledge survey responses were analyzed using frequencies and dependent t-tests.   
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In the knowledge section, there were a total of 17 correct responses to the 10 select-all-that-apply 
questions.  Participants received credit for each correct response when computing summary 
measures for dependent t-tests.  Responses of “other,” “don’t know,” and “N/A” were not 
included.  Changes in participant attitudes, skills, and knowledge were summarized for each 
question as the number and percentage of participants who did not provide an accurate response 
prior to receiving the educational intervention for the specified content area yet responded 
correctly after receiving the intervention.  Frequency of the knowledge survey responses were 
analyzed individually looking at the correct responses for each of the 10 knowledge questions.  
T-tests of staff and providers’ averaged knowledge scores out of 17 possible correct responses 
were also analyzed.  
At the final information session on December 13, 2019, the DNP student explored the 
project team members’ thoughts on hepatitis risk screening with use of the HRAT.  Informal 
comments and responses at the final information session were manually recorded and transcribed 
to analyze for common themes or patterns related to barriers to screening, perceptions of 
hepatitis risk assessments in the practice, and the advantages and disadvantages of the project 
outcomes.  
Part 2: Hepatitis Risk Screening. 
Hepatitis Risk Assessment Tool utilization intervention. At the first information session, 
the DNP student identified the project team who would be responsible for implementing the 
HRAT screening; and project responsibilities were assigned.  The staff responsibilities and risk 
screening procedures for each team member role are described below and are summarized in 
Appendix I.   
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Licensed practical nurse role.  The LPN was responsible for administering routine 
HRATs (Appendix A) to all adult patients ages 18 years and older who were seen by the PA.  
The LPN was encouraged to assist patients in completing the demographic section and the 15 
risk assessment questions of the tool.  This was accomplished in the patient exam room prior to 
the patient meeting the PA.  The tool was placed on a colored clipboard that followed the patient 
from the initial LPN encounter of the visit to the exam rooms.  The colored clipboards allowed 
the project team members to easily visualize the location of the tool and determine if the tool is 
completed prior to patient checkout.   
Physician assistant role. The PA’s responsibility was to complete the “Provider Use 
Only” and “Provider Recommendation” sections of the HRATs in the exam rooms with the 
patients.  These HRAT sections reflect the PA’s evaluation of each patient’s hepatitis risk 
factors, vaccination status, hepatitis education delivery status, and recommendations for hepatitis 
vaccination and/or blood test screening.  If a patient had a positive screening result, the PA 
determined whether or not education and/or further management were needed, and followed up 
with appropriate teaching, other interventions, or referrals as needed.  The PA was also asked to 
collect and store the completed tools in her secured office.   
Office manager role. The OM routinely tracks the clinic’s patient volume.  The OM’s 
responsibility for the project was to report the patient numbers who were seen by the PA to the 
DNP student.  She reported these data via in-person or email.   
Data management of Hepatitis Risk Assessment Tool process. All data obtained from 
the HRATs were entered into Excel and then transferred to the SPSS Data Analysis Software 
program to compute descriptive and comparison statistics.   
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Analysis of Hepatitis Risk Assessment data. The DNP student recorded and computed 
the number of HRATs that were completed and the proportion of HRATs that were completed 
for eligible adult patient visits during the study period.  The proportion of successfully completed 
HRAT risk assessments was computed by dividing the number of HRATs that were thoroughly 
completed with the total number of adult patients seen by the PA during that same time period.  
Thoroughly completed HRATs are defined as HRATS that had no missing data, which means 
the HRATs were dated and all answers were marked for each section and question.  
Part 3: Community outreach.  
Community education intervention. On November 29, 2019, the DNP student 
participated in the Hmong New Year Celebration Festival in Catawba County for community 
engagement and to promote and increase hepatitis A, B, and C awareness.  The DNP student 
collaborated with Hmong Student Associations across the state to provide information at an 
educational booth.  Verbal education and informational pamphlets were provided to the people at 
the annual community event.  There were also opportunities to answer questions, and provide 
comments and feedback on viral hepatitis A, B, and C.      
Community outreach responses and analysis. To assess the degree of community 
awareness regarding hepatitis A, B, and C, the DNP student counted the number of individuals 
that received verbal education or an informational pamphlet. The DNP student tracked the 
attendance of individuals who received hepatitis education on a tally chart sheet, and also took 
field notes on questions and comments from the participants at the community event, to be used 
as qualitative feedback. 
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Application of Theories   
This DNP project used the Diffusion of Innovation Theory and concepts from the Culture 
Care Theory to support the implementation of the intervention aimed at improving patient 
outcomes with use of the HRAT and guide performance improvement efforts (see Table 4 & 
Table 5).   
Table 4. Application of the Five Components of the Diffusion of Innovation Theory in Hepatitis 
Risk Assessment Tool Utilization 
 Definition Application to DNP Project 
Knowledge Intended adopters are 
exposed to innovation but 
lack complete information 
At the staff and provider information 
sessions, the DNP student informed 
providers and staff about routine 
hepatitis risk assessments, vaccination 
and screening guidelines, hepatitis 
prevalence and incidence, and the 
critical need to screen.  
Persuasion Intended adopters become 
interested in the new 
innovation and seeks 
additional information 
The DNP student explored staff and providers’ 
interest of HRAT use by assessing the staff 
and providers’ attitudes and skills regarding 
hepatitis risk screening using the pre-test 
survey.  
Decision Intended adopters 
mentally apply innovation 
to practice and anticipated 
future practice, and then 
decide whether or not to 
adopt it 
The DNP student determined that the practice 
team applied the innovation of utilizing 
HRATs within their practice by collecting the 
completed tools periodically throughout 
intervention period.  
Implementation Intended adopters make 
full use of innovation 
At the final information session, the DNP 
student asked providers and staff about their 
thoughts on accepting or rejecting the practice 
change of providing routine HRATs to 
patients. 
Confirmation Intended adopters decide 
to continue the full use of 
innovation 
At the final information session, the DNP 
student asked the providers and staff about 
their thoughts of continuing HRAT utilization. 
Two providers reported that they plan to utilize 
a modified version of the HRAT as part of 




Table 5. Application of Diffusion of Innovation Theory’s Six Attributes to Successful Innovation 
of Hepatitis Risk Assessment Tool Utilization 
 Definition Application to DNP Project 
Relative 
Advantage 
Innovation has a clear, 
unambiguous 
advantage in either 
effectiveness or cost-
effectiveness that is 
easily adopted  
Staff were informed about the need for hepatitis risk 
screening versus no screening during the first 
information session (Appendix H).  The DNP 
student provided printed materials and clipboards; 
therefore, the HRAT process was at no cost to the 
project team. At the final information session, the 
DNP student asked the project team about their 
thoughts on the effectiveness of HRAT utilization.  
Compatibility Innovation is 
compatible with 
intended adopters’ 
values, norms, and 
perceived needs 
Specifically, the PA reported that she was interested 
in a quality improvement process that involved 
screening patients for hepatitis.  At the first 
information session, the DNP student had 
discussions with the staff and providers on their 
values, norms, and perceived needs for hepatitis risk 
screening in routine practice.  Their views on the 
need for risk screening are evaluated in the pre- and 




perceived as simple to 
understand and use by 
intended adopters 
The DNP student provided a simple and concise 
step-by-step risk screening process change guide 
(Appendix I) for the project team to follow.  
Trialability Innovation offers 
ability for 
experimentation and 
use on trial basis 
During the first information session, the DNP 
student offered opportunities for the project team to 
practice using the HRAT before the intervention 
period began.  
Observability Benefits of the 
innovation are visible 
to intended adopters 
Observed results could inform longer-term adoption 
or sustainability of the pilot intervention. At the final 
information session, the DNP student had 
discussions with the project team on whether there 
were any benefits to using the HRAT.   
Reinvention Innovation allows 
intended adopters to 
adapt, refine, or 
modify the innovation 
to their own needs 
Using PDSA cycles, the DNP student provided 
opportunities throughout the intervention period for 
providers and staff to refine or modify the HRAT 
utilization process to better meet their needs and 
office flow.  
 
To incorporate cultural care accommodation from the Culture Care Theory in this project, 
the DNP student shared concepts with staff and providers on how they can address barriers to 
hepatitis risk screening and health care decision-making complicated by potential Hmong 
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customs and practices at the information sessions (Table 6) (Fang & Stewart, 2018; Lor, 2017; 
Stratis Health, 2009).  To achieve cultural care preservation, education was provided to staff and 
providers on traditional Hmong practices that are sometimes used to help alleviate hepatitis 
symptoms, and how the staff should address these practices (CDC, 2008).   
Table 6. Application of Culture Care Accommodation and Preservation  
 
Hmong Practices 
Provider and/or Staff 
Response to Provide 
Culturally Competent Care 
Culture Care Accommodation 
 Before making a decision, many 
Hmong like to get a second 
opinion, often from clan leaders, 
to be sure they are making the 
appropriate decision  
Refrain from pressuring 
patients for a decision before 
they have had time to consult 
with others 
 
 Patient may refuse screening 
because of fear of bad reputation 
such as “unclean person” in 
family and community 
Explain to the patient that 
results of hepatitis screen is 
confidential 
 
 Adults may have strings tied 
around wrists, waists, or ankles 
for good luck, fortune, or 
blessings 
Never remove strings, 
necklaces, or bracelets 
without patient’s permission 
Culture Care Preservation 
 A Hmong patient may present 
with unusual physical markings, 
such as bruises or redness, on his 
or her body. These markings may 
be the result of traditional 
healing practices, such as 
cupping, spooning, coining, or 
acupuncture to help alleviate 
symptoms such as abdominal 
pain, joint pain, fever, or fatigue 
Inquire about the use of 
traditional practices or 
medicines  
 
 If strings are tied around a young 
child or infants’ neck for good 
luck, fortune, or blessings, this 
may be a choking hazard 
Recommend that parents or 
caretakers to relocate the 
string to the patient’s wrists, 
waists, or ankles instead for 




The proposal for this project was approved in March 2019 by the project committee.  An 
approval from the Office of Human Research Ethics Institutional Review Board (IRB) at the 
University of North Carolina (UNC) at Chapel Hill was requested in May 2019.  On June 18, 
2019, the project was determined to be exempt from IRB approval as it does not constitute 
human subjects research (Appendix G).   
Prior to project implementation, the staff and providers were made aware that this project 
is affiliated with the School of Nursing at UNC Chapel Hill.  This project did not require the 
DNP student to have contact with patients nor did it allow the DNP student to view patient 
charts.   
De-identified pre- and post- intervention surveys (Appendices B and C) were kept 
confidential by using PID numbers.  The surveys did not ask staff or provider participants for 
any personal identifiers.  Furthermore, the HRAT (Appendix A) did not inquire any personal 
patient identifying information.  The risk assessment tools were optional for patients to complete.  
The PA and LPN were also responsible to validate that no patient identifiers were accessible to 
the DNP student.  Additionally, no personal information was collected from individuals during 
the community outreach event.  
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CHAPTER 6: RESULTS  
Part 1: Staff and Provider Survey Responses 
 Pre- and post- intervention survey participants.  Four providers and seven office staff 
completed the pre-intervention and post-intervention surveys.  One other eligible staff member 
was not interested in the project and did not participate.  The sample size (n) is the number of 
participants who completed both the pre- and post- intervention surveys (n=11) (Figure 1).   
Figure 1. Participants of the Pre- and Post- Intervention Surveys 
 
Attitudes and skills survey results.  In general, the mean survey scores for staff and 
provider attitudes and skills towards screening patients for hepatitis risks did not improve from 
the pre-intervention to the post-intervention period (Table 7).  The attitudes and skills decreased 




























Staff and Provider Survey Participants
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attitudes and skills questions, the mean score differences ranged from -2.09 to 0.08.  There was 
only one marginally positive increase (+ 0.08) for the question assessing the confidence level in 
suggesting follow-up recommendations and resources to patients who are positive for hepatitis.  
The greatest difference in comparing the attitudes and skills from pre to post test was that staff 
and provider motivation levels for hepatitis risk screening had decreased by 2.09.  
There were 10 positive responses from staff and providers to the first attitude question of 
the pre-intervention survey, “Routine hepatitis risk assessment is an important part of the 
patients’ health history.”  The responses were: two agree, eight strongly agree, and one negative 
response of strongly disagree.  For this same question in the post-intervention survey, there were 
seven positive responses of five agree and three strongly agree, three negative responses of 
strongly disagree, and one neither response.  The mean score dropped by 1 full point on the five-
point scale and two additional people strongly disagreed with the importance of this screening 
For the second attitude question, “Hepatitis A and B vaccinations are safe and effective,” 
there were 10 positive responses from staff and providers in the pre-intervention survey that 
consisted of four agree and six strongly agree, and one negative response of strongly disagree.  In 
the post-intervention survey, there were eight positive responses of five agree and three strongly 
agree, and three negative responses of strongly disagree.  The mean score dropped by almost one 
point on the five-point scale and two additional people strongly disagreed with the safety of these 
vaccinations.   
For the third attitude question, “I am motivated to screen patients for hepatitis risks,” 
there were eight positive responses from staff and providers in the pre-intervention survey that 
consisted of three agree and five strongly agree, one negative response of strongly disagree, and 
one neither response.  In the post-intervention survey, there were four positive responses of two 
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agree and two strongly agree, two negative responses of strongly disagree, and five neither 
responses.  The mean score dropped by two points on the five-point scale and four less people 
responded as “agree” or “strongly agree” to being motivated to screen.  There was one more 
“strongly disagree,” one more “neither agree or disagree,” and two more “not applicable” 
responses. 
For the fourth attitude question, “I feel comfortable caring for patients who are positive 
for hepatitis,” there were nine positive responses from staff and providers in the pre-intervention 
survey that consisted of six agree and three strongly agree, one negative response of strongly 
disagree, and one neither response.  In the post-intervention survey, there were six positive 
responses of five agree and one strongly agree, two negative responses of strongly disagree, and 
three neither responses. 
For the first skills question, “I feel confident talking to patients about hepatitis risks,” 
there were eight positive responses from staff and providers in the pre-intervention survey that 
consisted of two agree and six strongly agree, two negative responses of one strongly disagree 
and one disagree, and one neither response.  In the post-intervention survey, there were seven 
positive responses of five agree and two strongly agree, two negative responses of strongly 
disagree, and two neither responses.  The mean score dropped by one point on the five-point 
scale and four less people responded as “strongly agree, shifting three additional responses to 
“agree” and one additional response to “strongly disagree” about feeling confident in talking 
with patients about hepatitis risks.   
For the second skills question, “I can recognize at-risk patients for hepatitis based on 
their health,” there were seven positive responses from staff and providers in the pre-intervention 
survey that consisted of four agree and three strongly agree, two negative responses of one 
 
40 
strongly disagree and one disagree, and two neither response.  In the post-intervention survey, 
there were seven positive responses of six agree and one strongly agree, two negative responses 
of strongly disagree, and two neither responses. 
For the third skills question, “I am confident offering screenings to patients,” there were 
six positive responses from staff and providers in the pre-intervention survey that consisted of 
two agree and four strongly agree, two negative responses of one strongly disagree and one 
disagree, and three neither response.  In the post-intervention survey, there were six positive 
responses of five agree and one strongly agree, two negative responses of strongly disagree, and 
three neither responses.  The mean score dropped by 0.64 points on the five-point scale and three 
less people responded as “strongly agree, shifting three additional responses to “agree” and one 
response to from “disagree” to “strongly disagree” about feeling confident in offering screenings 
to patients.   
For the fourth skills question, “I am confident when suggesting follow-up 
recommendations and resources to patients who are positive for hepatitis,” there were six 
positive responses from staff and providers in the pre-intervention survey that consisted of three 
agree and one strongly agree, three negative responses of two strongly disagree and one disagree, 
and three neither response.  In the post-intervention survey, there were seven positive responses 
of five agree and two strongly agree, two negative responses of strongly disagree, and two 
neither responses. 
On a whole, they started with 64 positive responses, and in post-intervention there were 
52 positive responses.  In comparison to the negative responses, they started with 13 negative 
responses, and in post intervention there were 18 negative responses.  Although there are   
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negative trends when comparing pre-intervention to post-intervention, the results yield more 
positive responses than negative responses as a whole.  This means that most of the respondents’ 
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Knowledge results.  Staff and providers knowledge on viral hepatitis improved overall 
after the intervention.  Table 8 displays the number and percent of respondents who correctly 
answered each knowledge question in the pre- and post- surveys.  Knowledge improved in eight 
out of 10 content areas.  Staff and providers had the most knowledge improvement in two 
questions.  The percentage of respondents who answered question five correctly, regarding 
which virus types can survive outside the body the longest, increased by 64 percentage points 
from 27% to 91%.  And, the percentage of respondents who answered question 10 correctly, 
regarding the relative HBV-associated mortality among the Asian population in the United 
States, also increased by 64 percentage points, from 18% to 82%.  The two questions that 
experienced a slight negative trend in knowledge percentages were questions 6 and 9.  These 
were focused on which hepatitis type(s) an individual is at risk for if they are born outside of the 
United States (- 9 percentage points) or had received clotting factors before 1987 (-9 percentage 
points).  The most common incorrect answer choice for question 6 was HBV alone (9 
respondents of 11) and the most common incorrect answer choice question 9 was HBV and HCV 
(5 respondents of 11).    
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Table 8. Number and Percent of Respondents who Answered Knowledge Questions Out of 10 
Possible Correct Responses in Pre- and Post- Intervention Surveys 














1 What type(s) of hepatitis vaccines are 
available? 
5 (45%) 10 (91%) + 46% 
 
2 Depending on the genotype, a curative 
treatment is offered for which type(s) of 
hepatitis? 
4 (36%) 8 (73%) + 37% 
3 Fever, fatigue, loss of appetite, nausea, 
vomiting, and abdominal pain are more 
common symptoms among which type(s) of 
hepatitis? 
3 (27%) 6 (55%) + 28% 
4 Which type(s) of hepatitis is chronic, can 
lead to liver diseases, and/or cancer? 
4 (36%) 7 (64%) + 28% 
5 Which virus(s) can survive outside the body 
surfaces longest? 
3 (27%) 10 (91%) + 64% 
6 People born outside the United States are at 
higher risk for which type(s) of hepatitis? 
1 (9%) 0 (0%) - 9% 
7 The USPSTF recommends screening people 
born between 1945-1965 for which 
hepatitis? 
7 (64%) 10 (91%) + 27% 
8 Men who have anal sex with men are at 
higher risk for which type(s) of hepatitis? 
0 (0%) 5 (45%) + 45% 
9 Patients with clotting factor disorder(s) or 
who received clotting factor concentrates 
before 1987 are at higher risks for which 
type(s) of hepatitis? 
5 (45%) 4 (36%) - 9% 
10 Hepatitis B associated mortality is 11 times 
higher among which patient population in 
America? 
2 (18%) 9 (82%) + 64% 
 
 
Group statistics of staff and providers’ knowledge scores in pre- and post- 
intervention surveys.  Table 9 shows the paired differences in the pre- and post- intervention 
survey scores out of 17 correct responses of the providers and staff’s knowledge of viral hepatitis 
A, B, and C.  These scores are the averaged or mean scores of the knowledge sections in the pre- 
and post- intervention surveys of staff and providers.  The mean scores of both the staff and 
providers (n = 11) knowledge increased from 54.18% to 80.55% (p = 0.001), demonstrating a 




Table 9.  Paired Differences of Staff and Providers’ Knowledge Scores Out of 17 Possible 
Correct Responses in Pre- and Post- Intervention Surveys, Using Paired T-Test 
  Pre-Survey  Post-Survey  
Mean 54.18% 80.55% 
Variance 481.16 150.27 
Observations 11 11 
df 10  
t Stat -4.08  
P(T<=t) one-tail 0.001  
 
Statistic comparison of staff versus providers’ knowledge scores in pre- and post- 
intervention surveys.  Table 10 and Table 11 shows the paired differences in the pre- and post- 
intervention surveys of the staff (n = 7) and providers’ (n = 4) knowledge survey scores out of 17 
possible correct responses of viral hepatitis A, B, and C as two separate groups.  When 
comparing the providers and staff’s knowledge scores, the staff’s mean score in the knowledge 
section increased from 43% to 81.29% (p = 5.135), while the providers increased slightly from 
73.75 to 79.25 (p=0.303).  This shows that the staff had a greater improvement in hepatitis A, B, 
and C knowledge as evidenced by improved correct answers after the project intervention as 
compared to the providers.  However, when comparing the mean post-survey scores of each 
group, the staff had a slightly higher mean score of 81.29% when compared to the providers’ 
mean post-survey score of 79.25%.  
Table 10.  Paired Differences of Staff’s Knowledge Scores Out of 17 Possible Correct Responses 
in Pre- and Post- Intervention Surveys, Using Paired T-Test 
  Pre- Survey  Post- Survey  
Mean 43% 81.29% 
Variance 351.67 199.57 
Observations 7 7 
df 6  
t Stat -9.04  




Table 11.  Paired Differences of Providers’ Knowledge Scores Out of 17 Possible Correct 
Responses in Pre- and Post- Intervention Surveys, Using Paired T-Test 
  Pre- Survey  Post- Survey  
Mean 73.75% 79.25% 
Variance 98.25 98.25 
Observations 4 4 
df 3  
t Stat -0.57  
P(T<=t) one-tail 0.303  
 
 Staff and provider qualitative feedback at final information session.  Themes of the 
project team members’ views on use of the HRAT are presented in Tables 12, 13, and 14.  These 
themes include: the advantages and disadvantages of HRAT use in the practice and other 
comments on HRAT implementation.   
Table 12.  Post Intervention: Staff and Provider Responses to the Benefits of HRAT Utilization  
“[Anonymous provider] wants clinic to stock and provide hepatitis A and B vaccine to 
patients.” 
“[Anonymous provider] wants to use a modified version of the tool. Just the 15 risk 
questions.” 
“The tools help with quality measures” 
“We identified 3 or 4 [Hmong] patients with positive hepatitis results, and 1 or 2 patients have 
seen GI [gastroenterology]” 
 
Table 13. Post Intervention: Staff and Provider Responses of the Disadvantages of HRAT 
Utilization 
“Patients who were recommended for vaccines requested for the vaccines in-office, but we 
don’t carry it here, so they weren’t able to receive it” 
“I have some patients with concerns for hepatitis B screening coverage” 
“It’s a little time-consuming [HRAT process]” 
 
Table 14. Post Intervention: Other Comments from Staff and Provider Responses Concerning 
HRAT Utilization 
“Some patients completed the tool once and did not want to do it again at later visits.” 
“One to two patients refused [filling out the HRAT]” 
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Part 2: Hepatitis Risk Assessment Tool Results  
HRAT utilization.  During the intervention period, from September 5, 2019 and 
November 26, 2019, the office manager reported that 452 patients were seen by the PA.  Of 
those 452 patients, 196 tools were turned in to the DNP students and data was entered and used 
for analysis of the results.  Of the 196 tools turned in, 10 had missing dates as to when they were 
completed, and seven had missing data.  Data from the 196 tools were analyzed.  There were 186 
(94.9%) HRATs thoroughly completed by the participating patients and project team.  With 452 
patients seen by the provider and 196 turned into the DNP student, utilization of the HRAT by 
the PA at this office was 43.4%.  See Appendix K for daily results. 
Patient demographics.  Ethnicity was reported by 191 patients of the 196 (97.4%) 
completed HRATs (Table 15).  Of those patients reporting ethnicity, 21 (11%) self-reported as 
Hmong, 13 (6.8%) as Asian, and 157 (82.1%) as non-Hmong and non-Asian (Table 16).  The 
most common age group of the Hmong patients assessed for hepatitis risks were 50 to 59 years 
old (n = 6; 28.6% of 21); while the most common age group of the Asian (n = 4; 30.8% of 13) 
and Non-Hmong Non-Asian (NHNA) (n = 61; 38.9% of 157) patients were 30-49 years old 
(Figure 2).   
Furthermore, 17 (81% of 21) Hmong patients self-identified as female and 4 (19% of 21) 
as male; while 6 (81% of 13) patients reported being Asian females, 6 (46.2% of 13) as Asian 
males, 114 (72.6% of 157) as NHNA females, and 54 (34.4% of 157) as NHNA males (Figure 
3).  The most commonly reported insurance types for Hmong patients were Medicaid (n = 10; 
47.6% of 21) and Medicare (n = 10; 47.6% of 21); while the most common insurance type for the 
Asian patients was Medicaid (n = 6; 46.2% of 13), and private insurance for NHNA patients (n = 
76; 48.4% of 157) (Figure 4).  
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Table 15. Frequency of Ethnicity of Patients Screened for Hepatitis Risks 
Ethnicity Frequency of Patients Screened for Hepatitis Risks 
 Frequency 
(n) Percent 
 Hmong 21 11 




Total 191 100.0 
Did Not Report  5  
Total 196  
 
Figure 2. Number of Hmong, Asian, and Non-Hmong Non-Asian Patients Screened for Hepatitis 
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Figure 3. Number of Hmong, Asian, and Non-Hmong Non-Asian Patients Screened for Hepatitis 




Figure 4. Number of Hmong, Asian, and Non-Hmong Non-Asian Patients Screened for Hepatitis 
Risks, Stratified by Insurance Type 
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American-born individuals who were not vaccinated as infants whose parents were born outside 
of the United States (USPSTF, 2014; CDC, 2016a; Sarin et al., 2016; Nguyen & Lin, 2015).  
Nearly all of the Hmong (95.2%; n=20 of 21 patients) and Asian (100%; n=13 patients) patients 
answered “yes” to being born or having at least one parent born outside of the United States 
compared to only 7 percent (n=11 of 157 patients) of the NHNA patients (Table 17).  The 
NHNA patients reported a variety of hepatitis risks, including history of a diagnosis of clotting 
factor disorder (2.5%; n=4 of 157 patients), sexually transmitted disease (1.3%; n = 2 of 157 
patients), men having sexual intercourse with other men (1.3%; n = 2 of 157 patients), drug 
injection user (1.3%; n = 2 of 157 patients), or current drug injection user (1.3%; n = 2 of 157 
patients); while the Hmong and Asian patients did not self-report any of these risk factors.  Table 
16 shows the frequency of patients answering yes to the 15 hepatitis risk assessment questions.   
Table 16. Patient Responses to Hepatitis Risk Assessment Questions 
 Number (Percent) Yes Responses 
Hepatitis Risk Assessment Questions Hmong Asian NHNA 
1. Have you ever been diagnosed with a clotting factor disorder? 0 (0%) 0 (0%) 4 (2.5%) 
2. Have you ever been diagnosed with a chronic liver disease? 1 (4.8%) 0 (0%) 4 (2.5%) 
3. Were you or at least one parent born outside of the United States? 
20 
(95.2%) 13 (100%) 11 (7%) 
4. Do you currently live with someone who is diagnosed with 
Hepatitis B? 0 (0%) 4 (30.8%) 0 (0%) 
5. Have you previously lived with someone who has been diagnosed 
with hepatitis B? 3 (14.3%) 2 (15.4%) 1 (0.6%) 
6. Have you recently been diagnosed with a sexually transmitted 
disease? 0 (0%) 0 (0%) 2 (1.3%) 
7.   Have you been diagnosed with diabetes? 5 (23.8%) 1 (7.7%) 42 (26.8%) 
8. Have you been diagnosed with HIV/AIDS? 0 (0%) 0 (0%) 0 (0%) 
9.   If you are a man, do you have sexual encounters with other men? 0 (0%) 0 (0%) 2 (1.3%) 
10. Do you currently inject drugs? 0 (0%) 0 (0%) 2 (1.3%) 
11. Were you born from 1945-1965? 8 (38.1%) 1 (7.7%) 54 (34.4%) 
12. Have you ever received a blood transfusion or organ transplant 
before July 1992? 0 (0%) 2 (15.4%) 5 (3.2%) 
13. Have you ever received a clotting factor concentrate before 1987? 0 (0%) 0 (0%) 0 (0%) 
14. Have you ever injected drugs, even if just once? 0 (0%) 0 (0%) 2 (1.3%) 
15. Do you plan on traveling outside the United States within the next 
year? 4 (19%) 1 (7.7%) 16 (10.2%) 
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Patients with hepatitis risks as identified by provider.  All Hmong patients with no 
missing data were identified to have risks for viral hepatitis (Table 17).  Of the 21 Hmong 
patients, 20 (95.2%) were identified by the provider as having hepatitis B risks.  Similarly, 12 
(92.3% of 13) of the Asian patients had hepatitis B risks.  When compared to the NHNA 
patients, only 16.6% (n = 26 of 157) patients were at risk for hepatitis B.  Six Hmong patients 
(28.6% of 21), one Asian patient (7.7% of 13), and seven NHNA patients (4.5% of 157) were at 
risk for more than one hepatitis type, which were HBV and HCV.  One NHNA patient was 
identified to have risk for all three hepatitis types, and he responded “yes” to question two, 
“Have you ever been diagnosed with a chronic liver disease?” and question seven, “Have you 
been diagnosed with diabetes?” in the HRAT.  The PA identified 20 Hmong patients (95.2% of 
21), 12 Asian patients (92.3% of 13), and 77 NHNA patients (49% of 157) who had at least one 
hepatitis risk.  In total, there were 109 patients who self-reported their ethnicity (57.1% of 191) 
that were identified by the PA to have hepatitis risks.  
Table 17. Patients with Hepatitis Risks as Identified by Provider in Hepatitis Risk Assessment 
Tools 
Patients with Hepatitis Risks 
Identified by Provider 
Number (Percent) 
Hmong Asian NHNA 
No risks 0 (0%) 0 (0%) 79 (50.3%) 
HAV 0 (0%) 0 (0%) 3 (1.9%) 
HBV 20 (95.2%) 12 (92.3%) 26 (16.6%) 
HCV 6 (28.6%) 1 (7.7%) 58 (36.9%) 
2 Hepatitis Types 6 (28.6%) 1 (7.7%) 7 (4.5%) 
3 Hepatitis Types 0 (0%) 0 (0%) 1 (0.6%) 
Provider Did Not Report 1 (4.8%) 0 (0%) 1 (0.6%) 
 
 Patients who received hepatitis education from the provider.  The PA provided 
hepatitis education through use of a patient education printout from the CDC to seven Hmong 
patients (33.3% of 21), one Asian patient (7.7% of 13), and 56 NHNA patients (35.7% of 157).  
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She provided verbal hepatitis education to 16 Hmong patients (76.2% of 21), n=11 Asian 
patients (84.6% of 13), and n = 109 NHNA patients (69.4% of 157).  Four Hmong patients (19% 
of 21), one Asian patient (7.7% of 13), and 109 NHNA patients (16.6% of 157) received both the 
CDC printout and verbal education.  Seven NHNA patients (4.5% of 157) declined education, 
while there were missing data for one Hmong patient (4.8% of 21), two Asian patients (15.4% of 
13), and 11 NHNA patients (7% of 157) regarding hepatitis education.  Out of 191 patients who 
self-identified their ethnicity, 170 patients (89%) received education.  See Figure 5 for frequency 
of patients who received hepatitis education.   
Figure 5. Frequency of Hmong, Asian, and Non-Hmong Non-Asian Patients Who Received 
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obtain the hepatitis A vaccine.  The PA provided recommendations to 17 Hmong patients (81% 
of 21), 11 Asian patients (52.4% of 13), and 105 NHNA patients (66.9% of 157) to receive the 
Hepatitis B vaccine based on the patients’ risk factors.  Additionally, there was one NHNA 
patient who was recommended to receive both vaccines, and this patient answered “yes” to 
questions 14, concerning use of drug injection.  Out of 191 patients who identified their 
ethnicity, the provider recommended hepatitis vaccinations for 168 patients (88%).  See Figure 6 
for frequency of patients recommended by the PA for vaccinations.   
Figure 6. Frequency of Provider Recommendation for Hepatitis Vaccination in Hmong, Asian, 




Patients with risk factors who were recommended by the provider for hepatitis 
blood testing.  Hepatitis B blood testing was recommended by the PA for four Hmong patients 
with HBV risks (20% of 20) and three Asian patients with HBV risks (25% of 12).  Hepatitis C 
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NHNA patients (56.9% of 58).  Both tests were recommended for three Hmong patients, two 
Asian patients, and three NHNA patients.  The PA gave other recommendation options to 10 
Hmong patients, seven Asian patients, and 70 NHNA patients.  The PA identified one Hmong 
patient and 47 NHNA patients with no indication for blood testing.  One Asian patient and eight 
NHNA patients declined blood testing; and there were missing data for one Hmong patient and 
two NHNA patients.  See Figure 7 for frequency of recommended hepatitis blood testing by the 
provider for patients with positive risks. 
Figure 7. Frequency of Patients with Positive Risk Factors who Were Recommended to Have 




Patients with positive risk factors who received follow-up instructions.  The PA was 
expected to give follow-up instructions to patients who were identified with positive risk factors.  
The PA provided follow-up instructions to 13 Hmong patients (65% of 20) and eight Asian 
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factors; however, the PA gave follow-up instructions to 93 NHNA patients (120.8% of 77).  
Conversely, of the 77 NHNA patients with positive risk factors, only 58 (75.3%) received 
follow-up instructions.  In total, the PA gave follow-up instructions to 114 patients.  
Provider-identified hepatitis C risk factors among 60 to 69-year-old patients.  The 
CDC reports that individuals who are born between 1945 and 1965 have HCV risks and are 
recommended for HCV blood test screening (CDC, 2018a).  Patients who self-reported their age 
to be in the 60 to 69-year-old age range should be identified by the provider to be at risk for 
HCV.  Out of the 187 patients who identified their age range, 34 patients (18.2%) identified as 
being in the 60 to 69-year-old range.  Four (11.8%) of the 34 patients inaccurately answered “no” 
in their HRAT to question 11, “Were you born from 1945-1965?”  Therefore, three of those four 
patients were not identified as being at risk for hepatitis C by the provider; the fourth patient was 
identified by the provider as being at risk for hepatitis C because the patient responded “yes” to 
question 10, “Do you currently inject drugs?”   
Of the 34 patients identified as being in the 60 to 69 year age range, 29 (85.3%) were 
accurately identified by the provider as being at risk for hepatitis C (Figure 7).  The provider 
reported that three of those patients had not previously been screened for hepatitis C.  The 
provider gave follow-up instructions to 100 percent (n = 3) of those patients.  She recommended 
blood test screening for two of the patients who were at risk for HCV and have never been 
screened before; and she reported “other” follow-up lab work screening options for the third 
patient.   
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Insurance status of patients with positive hepatitis risks who declined hepatitis 
blood test screenings.  Nine patients, who were identified by the provider at being at risk for 
hepatitis, declined hepatitis blood test screening.  One patient (11.1%) was Asian and eight 
(89.9%) were NHNA patients. The Asian patient had both Medicare and Medicaid coverage, 
while the other patients had private insurance, Medicaid, Medicare, or other insurance types.  
One of the patients, who had declined blood test screening, was NHNA and reported having a 
combination of private insurance, Medicaid, and Medicare.   
Part 3: Community Education Results 
On November 29, 2019, the DNP student met eight community members at the Hmong 
New Year Celebration Festival community event.  Information on viral hepatitis A, B, and C 
were given verbally, and all eight participants received printed handouts obtained from the CDC.  
One community member asked where patients should go to receive screening, and another asked 
about whether he or she should be worried if his or her partner has hepatitis.  All questions were 
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based on two themes: 1) unawareness of viral hepatitis risks (Table 18) and 2) unawareness of 
the prevalence of HBV and HCV among the Hmong population (Table 19).  
Table 18. Community Unawareness of Hepatitis A, B, and C 
“I didn’t know there were so many [hepatitis types]” 
“My sisters and I share razors. I didn’t know that sharing razors is a risk! ” 
“Didn’t know that you can get liver cancer from that” 
 
 
Table 19. Community Unawareness of HBV and HCV Prevalence Among the Hmong 
Population 
“Wow! That means that my whole family is at risk” 
“Thanks for telling us, where do we get this checked out at?” 
 
Results of Diffusion of Innovations Theory Applied to DNP Project 
Results of the components and attributes in the Diffusion of Innovation Theory that were 
applied to this DNP Project are presented in Tables 20 and 21. 




At the final information session, the project team reported to the DNP student 
that the utilization of the HRAT was somewhat effective in identifying at-risk 
patients for hepatitis. HRAT utilization was at no cost to the project team. 
The DNP student provided printed materials and clipboards.  
Compatibility The innovation for the need for hepatitis screening was initiated by the PA in 
the early stages of DNP project development. During the final information 
session, the PA reported that use of the HRAT is in sync with her and another 
provider’s values, norms, and their perceived needs in improving screening 
patients for hepatitis.  
Low 
Complexity 
The project team reported to the DNP student that the step-by-step risk 
screening process change guide (Appendix I) was simple to follow and the 
HRAT was easy to use.  
Trialability During the initial information session, the DNP student offered opportunities 
for the project team to practice using the tool before the intervention period 
began.  
Observability The PA reported that benefits of the HRAT included easy identification of 
patients with hepatitis risks and vaccination and follow-up instruction needs. 
Patients with positive hepatitis risks were referred to specialists and the local 
health department by the PA, which allowed them to observe the benefits of 
HRAT utilization.  
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Reinvention With use of the PDSA cycles, the DNP project provided opportunities 
throughout the intervention period for providers and staff to refine or modify 
the HRAT utilization process to better meet their needs and office flow. At 
the end of the intervention period, the PA and other providers asked for a 
modified version of the HRAT for future use.  
 
Table 21. Descriptive Results of the Diffusion of Innovation Theory’s Six Attributes 
 Results 
Knowledge At the staff and provider information sessions, the DNP student 
exposed providers and staff to routine hepatitis risk assessments, 
vaccination and screening guidelines, hepatitis prevalence and 
incidence, and the critical need to screen.  
Persuasion The PA reported that other providers were interested in the project 
collection data and requested for a preliminary report six weeks following 
the first informational session.  
Decision The DNP student confirmed that the project team utilized HRATs within 
their practice by collecting the completed tools periodically throughout 
intervention period.  
Implementation At the final information session, the DNP student asked providers and staff 
on their thoughts on accepting or rejecting the practice change of providing 
routine HRATs to patients. 
Confirmation Two providers reported that they plan to utilize a modified version of the 




CHAPTER 7: DISCUSSIONS   
Summary 
 The purpose of this DNP project was to increase hepatitis A, hepatitis B, and hepatitis C 
risk assessments in asymptomatic Hmong adult patients, utilizing the USPSTF’s 2014 Hepatitis 
B and 2013 Hepatitis C screening recommendations and the CDC’s recommendation for 
Hepatitis A and B immunizations.  The project was completed in collaboration with the project 
site team during the implementation period from September 4, 2019 to December 13, 2019 and 
was guided by the project committee members using the DoI and CCT.  Measures used in 
evaluating the intervention included provider and staff pre- and post- intervention surveys, 
HRATs, and qualitative feedback from office staff at the project site and community members at 
the Hmong New Year Celebration Event.    
Key Findings for Part 1 
The goals for Part One were to provide information sessions on viral hepatitis A, B, and 
C as an educational intervention to improve providers and staff attitudes, skills, and knowledge 
on hepatitis risk screening.  Although the study sample was small, the findings provided insight 
into how well the staff and providers view hepatitis risk screening measures and their 
understanding of hepatitis A, B, and C.   
The knowledge scores generally increased from the pre-intervention to the post-
intervention assessments.  More specifically, improvement in knowledge was higher among staff 
compared with the providers.  Because the staff and providers have a better understanding of the 
viral hepatitis risks, they may do a better job at recognizing patients with risks.  However, it was 
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surprising to see that the mean Likert scores for approximately half of the attitudes and skills 
questions dropped in the post-intervention assessment.   
Knowledge questions were based on objective correct answers on hepatitis risks.  
Attitude and skills questions were based on a Likert scale.  Based on the survey results, I believe 
there was a meaningful drop in about half of the attitudes and skills measures from the pre-
intervention to the post-intervention assessments. These findings were unexpected because the 
information sessions were intended to encourage staff and providers views to create behavioral 
changes in both attitudes and skills in regard to hepatitis risk screening.  These findings are also 
contradictory to a narrative review study that stated providers with more knowledge of hepatitis 
were more likely to screen their patients (Hu, 2008; Khalili et al., 2011; Kue & Thorburn, 2013).   
From the attitudes and skills survey results, the staff and providers’ positive or negative 
stance for each question was overall more clinically significant to evaluate in comparison to the 
frequency of responses per question.   Although there were substantive decreases in the mean 
scores in six out of eight attitudes and skills questions, over half of the respondents reported 
positive views on attitudes and skills in both the pre-intervention and post-intervention survey 
responses for each question (Table 7).  There were more positive responses compared to negative 
responses before and after implementation, meaning the respondents did feel that hepatitis risk 
screening had some significance.  The skills and attitudes questions with the highest proportion 
of positive responses were: routine hepatitis risk assessment is an important part of the patients’ 
health history, hepatitis A and B vaccinations are safe and effective, I feel comfortable caring for 
patients who are positive for hepatitis, and I feel confident talking to patients about hepatitis 
risks.   
 
62 
Another key point is that through use of the Culture Care Theory topics provided in the 
information sessions, staff and providers were able to incorporate culturally appropriate care to 
Hmong patients.  
Explanations for part 1 findings.  A possible explanation for knowledge improvement 
among providers is that the providers had higher baseline levels of knowledge.  Therefore, there 
was little improvement in the knowledge scores after the intervention in this group.  
There are several possible explanations for the negative changes in providers’ and staff’s 
attitudes and skills.  One possibility is that prior to initiation of the HRAT intervention, staff and 
providers were more interested in the project but later felt that use of the HRAT was time-
consuming and increased their workload burden.  See the Staff and Provider Post Intervention 
comments in Table 13.  Another possible explanation is that before the intervention, the staff and 
providers over-estimated their skills; and after they implemented the intervention, they realized 
that they had less skills than they originally thought.  It is also important to consider that staff 
who answered “not applicable” did not feel empowered to screen or did not have the authority to 
screen patients using the HRAT.  Examples are the lab technician and front desk personnel who 
did not play a role in the screening process.  
Attendance and turn-out for the information session at the beginning of the intervention 
was good.  Whereas, the attendance was low at the final providers and staff information session.  
The session took place on a Friday afternoon in mid-December.  Other than the PA, no other 
providers were present, and about half the office staff could not attend because of early leave or 
disinterest even though a meal was provided as an incentive.  Therefore, those who did not attend 
the session did not receive the verbal presentation, preliminary project results, discussions and 
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shared learning.  This is a significant factor that could have contributed to the negative attitudes 
and skills survey responses, as well as the knowledge scores.  
Key Findings for Part 2 
The goal for Part Two of this project was to increase hepatitis risk screening at the clinic 
by utilizing the HRAT to identify patients with hepatitis A, B, and/or C risks, assess provider 
recommendations, and also raise hepatitis awareness to the providers’ patient population.  
Through the use of the HRAT, the PA implementing the intervention successfully provided 
hepatitis education to and screened approximately 200 more patients than she had screened in the 
past within a 12-week period with a 43% HRAT utilization rate.  However, there was a decrease 
in the percentage of completed HRATs towards the last six-week period (Appendix K).   
As anticipated and in congruence with the literature (Dang & Chen, 2016; Gjerdingen & 
Lor, 1997; Mixson-Hayden et al., 2014; Sheikh, Atla, Ameer, Sadiq, & Sadler, 2012), the 
Hmong (95.2%) and Asian (92.3%) groups had the highest risk for HBV when compared to 
other ethnicities in this study (16.6%) (Table 16).  This was mainly attributed to their identified 
risk factor of being born or having a parent who was born outside of the United States (Table 
17).  Nearly all of the Hmong (95.2%) and Asian (100%) patients answered that they were either 
born outside of the United States or had at least one parent who was born outside of the United 
States (Table 16).  It may have been more beneficial to ask the patients their country of origin or 
their parent’s country of origin in the HRAT to be more thorough. 
A significant key finding is that the PA reported that there were three or four 
asymptomatic patients confirmed with hepatitis during this study.  It is important to note that all 
of those patients identified as Hmong.  This is equivalent to approximately 8.8% or 3 out of the 
PA’s 34 Hmong and Asian patient population at this practice.  In this small sample study, the PA 
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reported that all (100%) of the three or four patients living with hepatitis were unaware of their 
hepatitis status, compared to the FDA’s statement that approximately two-thirds of Asian 
individuals living in the United States with HBV are unaware of their hepatitis infection (FDA, 
2018).  Still, through use of the HRAT, hepatitis A, B and C risk awareness increased for 
providers, staff, and patients, 60% of patients received follow-up instructions, and nearly 90% 
received both information about hepatitis A, B and C and referrals for hepatitis vaccination.  
Most importantly, the provider identified that over half (57.1% or 109 of 191) of the patients she 
screened during the 12-week period had positive risks for hepatitis.   
Explanations for part 2 findings.  The decrease of completed HRATs in the last six-
week period could be attributed to patients who refused or had been screened earlier in the 
project period and did not want to repeat the HRAT.  This was evidenced by a statement made 
by the LPN in the qualitative assessment, “Some patients completed the tool once and did not 
want to do it again at later visits” in Table 14.  Another possibility is that the project team was 
too busy or had limited time for patients complete HRATs.   
Key Findings for Part 3 
The goal for Part Three of this project was to educate the Hmong community of Catawba 
County on hepatitis A, B, and C using information from the CDC.  The lack of awareness of 
viral hepatitis risk factors and prevalence among the Hmong population were evident (Tables 19 
and 20).  The information presented by the DNP student sparked an interest among community 
members, although only a few, to think about their own personal risk factors, such as viral 
transmission through sharing of toothbrushes and razors.  They made comments on the 
importance of the information presented, thus serving as a stimulus to share the information with 
their family members and peers.   
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Strengths of the Intervention 
There were several identified strengths in the implementation of this project.  The PA and 
LPN were project champions and played critical roles in provider and staff participation and the 
success of the HRAT intervention.  The PA encouraged office staff and provider participation in 
both surveys, while the LPN initiated HRAT administration to patients.  Otherwise, the sample 
size of staff and provider and HRATs could have potentially been smaller.  Additionally, because 
the PA and LPN are Hmong, they may have provided culturally competent care in serving the 
target population.  It is also likely that the information about hepatitis risks, importance of 
screening, and high hepatitis prevalence among the Hmong individuals will be shared among the 
Hmong community.   
The consistency of focusing the HRAT intervention on one provider and exclusively her 
patients was beneficial in making the DNP project less complex.  Other strengths were use of the 
PDSA cycles and shared learning through weekly contact with the project team.  The rapid 
cycles were essential in the ongoing assessment of the HRAT intervention and contributed to 
improvements in the project site’s office flow.  
Costs of Project Implementation 
The costs for this project include time by care providers, staff, and the DNP student, 
supplies, transportation for the DNP student, and provider incentive meals.  However, no direct 
payments were made to support the project.  The DNP student and project team volunteered their 
time to plan and implement the project.  In addition, providers and staffs spent some time 
completing the HRAT surveys.  Supplies for this project consisted of clipboards and paper 
copies of the HRAT, CDC information pamphlets, and staff and provider information handouts.  
Other costs included staff and provider incentive meals that were provided during the two 
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information sessions, and gasoline cost for the DNP student, because the project site is 
approximately 150 miles from UNC.  The DNP student received a five hundred dollars award, to 
support this project, from the Sigma Theta Tau, Alpha Alpha Chapter Small Research Grant, 
which covered all costs.  
Project Limitations  
There are several limitations in this DNP project.  The major limitation of the project is 
that it was very specific to the partnering primary care office, as it was planned based on the 
needs of the PA, her patients, and the project site.  This project only looked at a limited patient 
population who were seen by one provider for hepatitis risk screening within a short 12-week 
time frame.  Pediatric patients and patients who were seen by other providers at the project site 
were not included in this study.  Other factors that limited the number of patients who were 
screened during this project is that the PA divided her workdays between the project site and 
another office, and she had taken a week off for vacation during this project period.  However, 
the reported number of patients seen by the PA from the OM may have included patients under 
18 years old; yielding a lower HRAT utilization percentage for this study.  Therefore, the 
findings cannot be generalized beyond the study setting because of the small sample size of 
patients, providers, staff, and completed HRATs.   
Because the pre- and post- intervention surveys and the modified HRATs collect self-
reported data and were first time uses, there is the potential for observation bias and issues with 
validity and reliability of data.  That is, self-reports of staff and provider attitudes, skills, and 
knowledge and patient hepatitis risks may be under- or overestimated because of inaccurate 
patient recall or desirability response bias.  The lower number of participants at the final 
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information session was another limitation.  This prevented a more accurate comparison to the 
pre-survey.   
Another factor is that the PA could have scored the patients’ risk factors inaccurately.  
For example, one NHNA patient was identified as needing both vaccinations, but only had one 
risk factor documented in the HRAT; indicating that the PA did not follow the CDC’s provider 
recommendation.  Another example is that one Hmong patient had HBV risks and had never 
been vaccinated prior to the visit with the PA, but was identified as not needing HBV blood 
screening.  
Additionally, there were limitations to the design and development of the HRAT and 
surveys using the Likert scale.  This is because the tools included the answer choices “don’t 
know” and “not applicable” that were later accounted as incorrect, which decreased the number 
of analyzed responses and could have made the results less meaningful.  Also, because the 
knowledge questions were in the form of select-all-that-apply, it could have been more difficult 
for staff and providers to choose the correct answers.  
Sustainability  
To maintain and improve hepatitis risk screening efforts at the primary care practice in 
the longer term, several recommendations can be made.  Most importantly, creating more buy-in 
from all office staff may be beneficial for screening success, as it requires collaboration from 
providers and staff (Armstrong & Sables-Baus, 2019).  Creating a system change that involves 
changing the clinic’s culture and daily office flow is expected to generate positive clinician 
behavior changes to adopt routine hepatitis screening (Armstrong & Sables-Baus, 2019).  
Delivering more frequent PDSA cycles and audit and feedback to stakeholders that include 
summary reports that address barriers with possible solutions may help support project 
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sustainability (Armstrong & Sables-Baus, 2019).  Ongoing education on viral hepatitis and risk 
screening process will need to be developed for the practice, especially for new staff and 
providers.  However, a different educational intervention approach may be more appropriate to 
motivate the staff and providers to learn and possibly change their attitudes and skills towards 
hepatitis screening.  Other evidence-based interventions should be explored.   
A shorter modified version of the HRAT or creating an electronic medical version in the 
patient’s chart for ease of tool completion and storage, may be more feasible for clinicians to 
administer to patients on a routine basis.  The hepatitis A risk assessment questions can be 
excluded as there was little indication for the need to screen for hepatitis A among the target 
population.  An electronic medical version that automatically scores the patients’ risks and 
follows the recommendation for referral, vaccines, or lab work is expected to help reduce 
provider recommendation errors (Jacobs, 2007).  Also, an electronic medical version may help 
with avoiding duplication of doing the screening repeatedly on returning patients.   
Implications for Practice 
Despite the project limitations, this quality improvement project provides valuable 
information that can be used to guide future hepatitis risk assessment strategies in health care, 
future research, and the development of educational programs for providers and staff to increase 
their awareness of hepatitis and its consequences.  One important significant clinical outcome 
was an increase in knowledge and awareness among providers and office staff of the need for 
routine hepatitis risk screening and the Hmong population’s high risk for hepatitis.  Other 
important implications are that use of the HRAT exemplified positive outcomes in hepatitis risk 
screening and patient education and may well serve as a foundation and model for future health 
care providers.  Through increased knowledge, use of risk screening tools, and evidence-based 
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implementation strategies, staff and providers could potentially identify patients with hepatitis 
earlier in the course of the disease, help further reduce hepatitis transmission among patients, as 
well as, meet hepatitis screening quality measures.   
Conclusions  
While this project did not demonstrate support for the interventional strategies in 
changing staff and providers’ attitudes and skills towards hepatitis risk screening, it was effective 
in increasing their knowledge about viral hepatitis and especially their awareness of the high 
prevalence of viral hepatitis among Asian patients, especially, the Hmong patients.  Additionally, 
hepatitis risk screening, by using a hepatitis risk assessment tool, is a feasible and effective 
intervention that was shown to increase hepatitis risk screening, increase patient hepatitis 
education, and improve provider recommendations to improve patient outcomes for those who 
are at risk for hepatitis A, B, or C.  Finally, through the community outreach, the DNP student 
was able to provide hepatitis education and awareness to Hmong community members in 





APPENDIX A: HEPATITIS RISK ASSESSMENT TOOL 
Hepatitis Risk Assessment Tool 
Choose one:   
 Today’s Date: _______________ 
         Circle one:               
1. Have you ever been diagnosed with a clotting factor disorder? 




2. Have you ever been diagnosed with a chronic liver disease? 





3. Were you or at least one parent born outside of the United States? 
Koj, koj niam, lossis koj txiv, puas yog yug txawv teb chaws meskas (United States)? 
Yes No  HBV blood test 
4. Do you currently live with someone who is diagnosed with Hepatitis B? 




HBV blood test 
5. Have you previously lived with someone who has been diagnosed with hepatitis B? 




HBV blood test 
6. Have you recently been diagnosed with a sexually transmitted disease? 
Kws kho mob puas tau kuaj pom hais tias koj muaj tus kab mob sib kis los ntaum kev 
ua niam txix? 
Yes No  HBV vaccine 
7.   Have you been diagnosed with diabetes? 
  Kws kho mob puas tau kuaj pom hais tias koj muaj ntshav qab zib? 
Yes No  HBV vaccine 
8. Have you been diagnosed with HIV/AIDS? 




9.   If you are a man, do you have sexual encounters with other men? 





HBV blood test 
10. Do you currently inject drugs? 
Koj puas niaj hnub txhaj yeeb txhaj tshuaj rau hauv koj lub cev? 





11. Were you born from 1945-1965? 
Koj puas yog yug nyob rau xyoo 1945-1965? 
Yes No  HCV blood test 
12. Have you ever received a blood transfusion or organ transplant before July 1992? 
Koj puas tau muaj ib zaug lawv tso ntshav ntxis pab rau koj lossis lawv hloov siab, 




HCV blood test 
13. Have you ever received a clotting factor concentrate before 1987? 
Puas tau muaj ib zaug lawv tso yam ntshav hu ua “clotting factor concentrate” pab rau 




HCV blood test 
14. Have you ever injected drugs, even if just once? 
  Koj puas tau txhaj yeeb txhaj tshuaj rau hauv koj lub cev dua li? 
Yes No  HCV blood test 
15. Do you plan on traveling outside the United States within the next year? 
  Xyoo tom ntej nos koj puas npaj mus txawv teb chaws? Yes No  
If yes, discuss 
vaccines needed for 
travel 
For Provider Use Only (choose all that apply) 




☐ No risk 
Is the patient vaccinated? 
☐ Hepatitis A 
☐ Hepatitis B 
☐ No 
☐ Unknown 





If positive risk factors: 
☐ Provided follow-up       
instructions 
☐ Patient declined 
 
Hepatitis Education: 
☐ Informational pamphlet 
☐ Verbal education 
☐ Patient declined 
 
Provider Recommendation (choose all that apply) 
Vaccination(s): 
☐ Hepatitis A       ☐ No indication     
☐ Hepatitis B       ☐ Patient declined 
Lab work screening:  
☐ HBV blood test     ☐ No indication     ☐ HCV blood test     ☐ Patient declined   
☐ Other 
Tool adopted from the Centers for Disease Control and Prevention Hepatitis Risk Tool 
Centers for Disease Control and Prevention. (2018b, September 13). Hepatitis Risk Assessment Tool. Retrieved 
from https://www.cdc.gov/hepatitis/riskassessment/index.htm  
Ethnicity 
☐ White  






☐ 18-29 years old 
☐ 30-49 years old  
☐ 50-59 years old  
☐ 60-69 years old 
☐ 70-79 years 







☐ Medicaid  






APPENDIX B: PRE-INTERVENTION SURVEY  
DNP Project Attitude, Skills and Knowledge Questionnaire for Health Care Providers and Staff 
Circle one response for each of the following items that best describe your personal perspectives about routine 














1. Routine hepatitis risk 
assessment is an important 
part of the patients’ health 
history 




2. Hepatitis A and B 
vaccinations are safe and 
effective 




3. I am motivated to screen 
patients for hepatitis risks 




4. I feel comfortable caring 
for patients who are 
positive for hepatitis 


















1. I feel confident talking 
to patients about hepatitis 
risks  




2. I can recognize at-risk 
patients for hepatitis based 
on their health history 




3. I am confident offering 
screenings to patients 




4. I am confident when 
suggesting follow-up 
recommendations and 
resources to patients who 
are positive for hepatitis 








APPENDIX B: PRE-INTERVENTION SURVEY 
Knowledge: 
     Choose all hepatitis types that apply 
1. What type(s) of 
hepatitis vaccines are 
available? 




2. Depending on the 
genotype, a curative 
treatment is offered for 
which type(s) of hepatitis? 




3. Fever, fatigue, loss of 
appetite, nausea, vomiting, 
and abdominal pain are 
more common symptoms 
among which type(s) of 
hepatitis? 




4. Which type(s) of 
hepatitis is chronic, can 
lead to liver diseases, 
and/or cancer? 




5. Which virus(s) can 
survive outside the body 
surfaces longest? 




6. People born outside the 
United States are at higher 
risk for which type(s) of 
hepatitis? 




7. The USPSTF 
recommends screening 
people born between 
1945-1965 for which 
hepatitis? 




8. Men who have anal sex 
with men are at higher risk 
for which type(s) of 
hepatitis? 




9. Patients with clotting 
factor disorder(s) or who 
received clotting factor 
concentrates before 1987 
are at higher risks for 
which type(s) of hepatitis? 




10.  Hepatitis B associated 
mortality is 11 times 
higher among which 
patient population in 
America? 









APPENDIX C: POST-INTERVENTION SURVEY  
DNP Project Attitude, Skills and Knowledge Questionnaire for Health Care Providers and Staff 
 
Circle one response for each of the following items that best describe your personal perspectives about routine 















1. Routine hepatitis risk 
assessment is an important 
part of the patients’ health 
history 




2. Hepatitis A and B 
vaccinations are safe and 
effective 




3. I am motivated to 
screen patients for 
hepatitis risks 




4. I feel comfortable 
caring for patients who are 
positive for hepatitis 


















1. I feel confident talking 
to patients about hepatitis 
risks  




2. I can recognize at-risk 
patients for hepatitis based 
on their health history 




3. I am confident offering 
screenings to patients 




4. I am confident when 
suggesting follow-up 
recommendations and 
resources to patients who 
are positive for hepatitis 









     Choose all hepatitis types that apply 
1. What type(s) of 
hepatitis vaccines are 
available? 




2. Depending on the 
genotype, a curative 
treatment is offered for 
which type(s) of hepatitis? 




3. Fever, fatigue, loss of 
appetite, nausea, vomiting, 
and abdominal pain are 
more common symptoms 
among which type(s) of 
hepatitis? 




4. Which type(s) of 
hepatitis is chronic, can 
lead to liver diseases, 
and/or cancer? 




5. Which virus(s) can 
survive outside the body 
surfaces longest? 




6. People born outside the 
United States are at higher 
risk for which type(s) of 
hepatitis? 




7. The USPSTF 
recommends screening 
people born between 
1945-1965 for which 
hepatitis? 




8. Men who have anal sex 
with men are at higher risk 
for which type(s) of 
hepatitis? 




9. Patients with clotting 
factor disorder(s) or who 
received clotting factor 
concentrates before 1987 
are at higher risks for 
which type(s) of hepatitis? 




10.  Hepatitis B associated 
mortality is 11 times 
higher among which 
patient population in 
America? 

























Analysis Results and  
Findings 
Quality of the 
Evidence 
Hu (2008) Review of barriers of 
HBV care in APIAs and 

















































Examine the roles of 
social norms and family 
discussion (FD) 
in HBV screening behav
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s: Asian A, 






















































who have FD 
about HBV 
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Melnyk Level II  
 
Strengths: large 
study size, one 
of few to 
examine social 
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HA, mindfulness 
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Khalili et al. 
(2011) 
HBV and HCC 
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among providers with 
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and men's knowledge of 
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Determine the 
prevalence of HBV and 
Hepatitis B vaccination 
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Asian A; review the 
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awareness, knowledge, 
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Legend: N, Sample size; RCT, randomized controlled trial; MAALCEP, Maryland Asian American Liver Cancer Education Program; HBV, Hepatitis B virus; 
APIA, Asian and Pacific Islander Americans; Asian A, Asian American; IN, injunctive norms; DN, descriptive norms; FD, family discussion; CA, California; 
RAM, Regression analysis model; CSS, Cross sectional study; SS, serologic screening; DMHQ, Demographic and medical history questionnaire; fx, family 
history; US, United States; CA, California; MLRA, Multivariable logistic regression analysis; CI, confidence interval; PCP, primary care providers; HCC, 









Centers for Disease Control and Prevention. (2016c, July 20). Hepatitis A VIS. Retrieved from 
https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hep-a.html 
  
 4 Risks of a vaccine reaction
With any medicine, including vaccines, there is a chance 
of side effects. These are usually mild and go away on 
their own, but serious reactions are also possible.
Most people who get hepatitis A vaccine do not have any 
problems with it.
Minor problems following hepatitis A vaccine include:




If these problems occur, they usually begin soon after the 
shot and last 1 or 2 days.
Your doctor can tell you more about these reactions.
Other problems that could happen after this vaccine:
•	People sometimes faint after a medical procedure, 
including vaccination. Sitting or lying down for about 
15 minutes can help prevent fainting, and injuries 
caused by a fall. Tell your provider if you feel dizzy, or 
have vision changes or ringing in the ears.
•	Some people get shoulder pain that can be more severe 
and longer lasting than the more routine soreness that 
can follow injections. This happens very rarely.
•	Any medication can cause a severe allergic reaction. 
Such reactions from a vaccine are very rare, estimated 
at about 1 in a million doses, and would happen within 
a few minutes to a few hours after the vaccination.
As with any medicine, there is a very remote chance of a 
vaccine causing a serious injury or death.
The safety of vaccines is always being monitored. For 
more information, visit: www.cdc.gov/vaccinesafety/
 5
  What if there is a serious 
problem?
What should I look for?
•	Look for anything that concerns you, such as signs  
of a severe allergic reaction, very high fever, or 
unusual behavior. 
 
Signs of a severe allergic reaction can include hives, 
swelling	of	the	face	and	throat,	difficu l ty 	breathing,	
a fast heartbeat, dizziness, and weakness. These 
would start a few minutes to a few hours after the 
vaccination.
What should I do?
•	If you think it is a severe allergic reaction or other 
emergency that can’t wait, call 9-1-1 or get to the 
nearest hospital. Otherwise, call your clinic. 
 
Afterward, the reaction should be reported to the 
Vaccine Adverse Event Reporting System (VAERS). 
Your	doctor	should	file 	this	report,	or	you	can	 
do it yourself through the VAERS web site at  
www.vaers.hhs.gov, or by calling 1-800-822-7967.
VAERS does not give medical advice.
 6
  The National Vaccine Injury 
Compensation Program
The National Vaccine Injury Compensation Program 
(VICP) is a federal program that was created to 
compensate people who may have been injured by 
certain vaccines.
Persons who believe they may have been injured by a 
vaccine	can	learn	about	the	program	and	about	fili ng 	a	
claim by calling 1-800-338-2382 or visiting the VICP 
website at www.hrsa.gov/vaccinecompensation. There 
is	a	time	limit	to	file 	a	claim	for	compensation.
 7 How can I learn more?
•	Ask your healthcare provider. He or she can give you 
the vaccine package insert or suggest other sources  
of information.
•	Call your local or state health department.
•	Contact the Centers for Disease Control and  
Prevention (CDC): 
- Call 1-800-232-4636 (1-800-CDC-INFO) or 
- Visit CDC’s website at www.cdc.gov/vaccines
  Vaccine Information Statement
 Hepatitis A Vaccine
  42 U.S.C. § 300aa-26
Offic
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What is viral hepatitis?
¤ An inflammatory condition of the liver caused by a 
virus
¤ 5 Types: A, B, C, D, E





















Acute: Hepatitis A does not become chronic; antibodies 
form to protect against re-infection
Chronic: 
¤ 6-10% Hepatitis B for adults (high for infants 90%)
¤ 15-25% chronically infected persons develop liver 
disease
¤ 75-85% newly infected Hepatitis C 
¤ 15-25% newly infected clears HCV





¤ 4.4 million people have chronic hepatitis







Hepatitis A Hepatitis B Hepatitis C
• Household members 
of caregivers of 
infected persons
• Men who have sex 
with men
• Sex contacts of 
infected persons
• Travelers to regions 
where HAV is 
common
• Persons with clotting-
factor disorders
• Sex partners of 
infected persons
• Persons with multiple 
sex partners
• Persons with a 
sexually transmitted 
disease (STD)
• Men who have sex 
with men
• Injection drug users
• Household contacts 
of infected persons
• Healthcare and 
public safety workers 
exposed to blood
• Hemodialysis patients
• Travelers to regions 
where HBV is 
common
• People born 
between 1945-1965
• Current or former 
injection drug users
• Recipients of clotting
factor concentrates 
before 1987






• Persons with known 
exposures to HCV
• Men who have sex 
with men
















Who are the Hmong?
• An ethnic group who 
emigrated from Southeast Asia 
starting in the 1970’s
• Hmong refugees have the 
highest rates of HBV and HCV 
infection compared to other 
refugee groups in U.S. 
• Have the highest rates of 
hepatitis infection overall
when compared to other 
Asian American groups












Hmong in U.S. 2010 Census
(Data USA, 2015; Gerdner, 2010)
North Carolina has 4th
largest Hmong population 
in U.S. (approx. 11,000)
2,865 native Hmong speakers residing 
Catawba County in 2015 
13
What are the symptoms?
¤ Most people don’t have symptoms












Hepatitis A Hepatitis B Hepatitis C 




• Sexual contact 
(rectal sex)
Exposure to blood,
semen, vaginal fluids, or 







equipment, or sharp 
instrument injuries
• Mother to baby at 
birth
• Can survive outside of 
body for up to 7 days











• Mother to baby 
at birth
• Can survive outside of 





Hepatitis A Hepatitis B Hepatitis C 
• All persons at risk
• Anyone seeking 
long-term 
protection
• 2 doses given 6 
months apart
• All infants at birth
• All persons who 
have not previously 
been vaccinated
• Anyone seeking 
long-term 
protection
• Infants/Children: 3-4 
doses given over a 
18 month period
• Adults: 3 doses 






























• > 18 years at increased 
risk for HBV and HCV
• Twinrex may be offered 
for free in STD clinic
(A. Bowers, personal communication, August 9, 2019; CDC, 2015)
*Free or reduced costs for children and patient’s who have positive 
Hepatitis C screening, STD(s), or men who have sex with men
17
Reportable Communicable Diseases
¤ HAV- 24 hours
¤ HBV- 24 hours
¤ Acute HCV - 7 days
Report to Catawba Health Department
Sarah Rhodes - Communicable Disease Clinical Supervisor




415 North Center Street, Suite 300, Hickory, NC
Catawba Valley Infectious Disease Consultants 
3412-B Graystone Plaza SE, Conover, NC
Catawba Family Care – Treats Hepatitis C
Heather Homesley - Hepatitis C Bridge Counselor at Catawba Health Dept.
Hepatitis A Hepatitis B Hepatitis C
Supportive treatment Acute: Supportive 
treatment
Chronic: Regular 
monitoring for liver 
disease progression; 
some patients treated 
with antiviral drugs




monitoring for liver 
disease progression; 
Direct acting antiviral 





¤ Increase screening patients for hepatitis risks
¤ Identify at-risk patients for hepatitis A, B, or C
¤Evaluate and improve providers’ and staff’s 
knowledge on routine hepatitis risk 
assessment screening, vaccination 










Hepatitis Risk Screening Tool
¤Adopted from the CDC
¤This tool screens for hepatitis risks
¤Distribute to all of Mai Vang’s patients 
ages 18+ years 
¤September through November 2019
21
Risk Screening Process
*Tool is for Mai Vang’s patients ages 18+ years*
22
Tips for Providing Culturally 
Competent Care to Hmong patients
¤ Ask your patients in what language they prefer to discuss 
their health. Use trained medical interpreters if needed; 
never use children or other family members as interpreters.
¤ Avoid making direct eye contact. Avoid hugging or 
shaking hands with the opposite sex. 
¤ Hmong may believe that illness is caused by a combination 
of natural and supernatural causes and may therefore seek 
a variety of specialists for diagnosis and treatment. Be sure 
to ask patients about their understanding of their illness and 
its cause. Show respect for these beliefs and tailor 
educational messages accordingly. 
¤ The Hmong have a vague understanding of cancer since 
the word “cancer” does not exists in their language. 
(CDC, 2008; Lor, 2018; Stratis Health, 2009)
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Culture Care Accommodation
¤ Before making a decision, many Hmong like to get a second 
opinion, often from clan leaders, to be sure they are making the 
appropriate decision 
¤ Refrain from pressuring patients for a decision before they 
have had time to consult with others
¤ Patient may refuse screening due to fear of bad 
reputation such as “unclean person” in family/community
¤ Ensure to the patient that results of hepatitis screen is 
confidential
¤ Adults may have strings tied around wrists, waists, or ankles for 
good luck, fortune, or blessings
¤ Never remove strings, necklaces, or bracelets without 
patient’s permission










¤ A Hmong patient may present with unusual 
physical markings, such as bruises or redness, on his 
or her body. These markings may be the result of 
traditional healing practices, such as cupping, 
spooning, coining, or accupuncture to help 
alleviate symptoms such as abdominal pain, joint 
pain, fever, or fatigue
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Licensed practical nurse (LPN) Responsibilities: 
• Administer HRAT to all adult patients 18+ years to be seen the PA 
o Instruct patients to complete the tool and give to the PA  
o Assist patients if needed 
 
Physician Assistant (PA) Responsibilities: 
• Provide hepatitis education verbally or give hepatitis education 
handout to patients 
• Complete provider’s portion of the tool 
• Store all completed tools in the PA’s office 
 
Office Manager (OM) Responsibilities 





















APPENDIX K: DAILY RESULTS OF COMPLETED TOOLS TO PATIENT 
ENCOUNTERS 
Daily Results of Completed Hepatitis Risk Assessment Tools to Number of Patients Encounters 
Assigned to the Physician Assistant 
Day Date Number of HRAT 
Completed 
Number of Patient 
Encounters Assigned to the 
Physician Assistant 
Percentage Completed 
1 9/4/2019 0 0 0.00% 
2 9/5/2019 5 5 100.00% 
3 9/6/2019 8 8 100.00% 
4 9/9/2019 9 12 75.00% 
5 9/10/2019 7 10 70.00% 
6 9/11/2019 5 6 83.33% 
7 9/12/2019 7 10 70.00% 
8 9/13/2019 5 6 83.33% 
9 9/16/2019 0 0 0.00% 
10 9/17/2019 12 16 75.00% 
11 9/18/2019 4 8 50.00% 
12 9/19/2019 8 8 100.00% 
13 9/20/2019 7 7 100.00% 
14 9/23/2019 7 13 53.85% 
15 9/24/2019 6 8 75.00% 
16 9/25/2019 3 6 50.00% 
17 9/26/2019 3 7 42.86% 
18 9/27/2019 2 3 66.67% 
19 9/30/2019 7 7 100.00% 
20 10/1/2019 5 8 62.50% 
21 10/2/2019 0 0 0.00% 
22 10/3/2019 3 10 30.00% 
23 10/4/2019 7 9 77.78% 
24 10/7/2019 6 10 60.00% 
25 10/8/2019 4 14 28.57% 
26 10/9/2019 4 9 44.44% 
27 10/10/2019 0 0 0.00% 
28 10/11/2019 0 0 0.00% 
29 10/14/2019 4 17 23.53% 
30 10/15/2019 3 12 25.00% 
31 10/16/2019 1 10 10.00% 
32 10/17/2019 0 12 0.00% 
33 10/18/2019 0 0 0.00% 
34 10/21/2019 2 5 40.00% 
35 10/22/2019 4 11 36.36% 
36 10/23/2019 2 7 28.57% 
37 10/24/2019 1 8 12.50% 
38 10/25/2019 4 4 100.00% 
39 10/28/2019 0 0 0.00% 
40 10/29/2019 0 0 0.00% 
41 10/30/2019 0 0 0.00% 
42 10/31/2019 0 0 0.00% 
43 11/1/2019 0 0 0.00% 
 
101 
44 11/4/2019 1 13 7.69% 
45 11/5/2019 0 12 0.00% 
46 11/6/2019 0 4 0.00% 
47 11/7/2019 8 14 57.14% 
48 11/8/2019 5 7 71.43% 
49 11/11/2019 4 17 23.53% 
50 11/12/2019 1 7 14.29% 
51 11/13/2019 0 0 0.00% 
52 11/14/2019 6 12 50.00% 
53 11/15/2019 0 0 0.00% 
54 11/18/2019 4 16 25.00% 
55 11/19/2019 1 15 6.67% 
56 11/20/2019 0 9 0.00% 
57 11/21/2019 0 13 0.00% 
58 11/22/2019 0 8 0.00% 
59 11/25/2019 1 12 8.33% 
60 11/26/2019 0 7 0.00%  
Totals 186 452 41.15% 
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